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Derivatives 
 
Jiliang Hang 
University of Nebraska, 2012 
 
Advisor: Patrick H. Dussault 
 
Phytosterols are steroid compounds structurally similar with cholesterol and vary in the 
nature of carbon side chain. β-Sitosterol is commercially available in preparative amount 
only as mixtures with other phytosterols. New semipreparative synthesis of pure β-
sitosterol and sidechain-modified phytosterols is discussed in this dissertation. This new 
synthesis is achieved via a temporary masking of the stigmasterol 5,6-alkene as an 
epoxide. Following performance of the desired modification, the alkene is regenerated 
through a mild deoxygenation. Preparation of phytosterol esters for cholesterol 
metabolism study is also discussed in this dissertation. 
 
Singlet oxygen (
1
O2) is the lowest excited state of oxygen molecule. Due to its special 
properties, 
1
O2 has been widely used as the oxidant in chemistry, biology, and medicine. 
In the past decades, two major generation methods have been developed, 
photosensitization and chemical generation. However, most of the reported chemical 
generations require the water-rich media, which is associated with short 
1
O2 lifetime as a 
 
 
major drawback. Therefore, there is a need for 
1
O2 generation from organic solvents. The 
investigation of fragmentation of monoactivated derivatives of 1,1-dihydroperoxides is 
discussed in this dissertation. This previously unobserved fragmentation can be 
conducted in various organic solvents and generate high yield of 
1
O2. This reaction is 
general for a range of skeletal frameworks and activating groups, and can be applied 
directly to 1,1-dihydroperoxides via in situ activation. Kinetic and mechanistic 
investigation suggests it involving rate-limiting formation of a peroxyanion, which 
decompose to generate 
1
O2 via Grob-like process.  
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Chapter 1 
Synthesis of pure β-sitosterol and other phytosterols 
(A portion of the results from this chapter have been published:  Hang J, Dussault PH, A 
concise synthesis of β-sitosterol and other phytosterols, Steroids, 2010, 75, 879-883) 
 
 
1. Introduction 
 
The term phytosterols refers to sterols and stanols synthesized in plants. The phytosterols 
have the same tetracyclic core structure as mammalian sterols such as cholesterol but 
differ in the presence or absence of a double bond at C22 and the nature of the 
substitution at C24..  Some examples are shown in Figure 1. Stigmasterol 1 is an 
unsaturated sterol, having one double bond in the sterol ring structure and one double 
bond in the side chain. β-sitosterol 2 is an unsaturated sterol with one double bond in 
sterol ring structure. Campesterol 4 is structurally similar to β-sitosterol but has a methyl 
substituent at C24 position instead of an ethyl group. Stigmastanol 3 is a saturated sterol 
both in sterol ring structure and side chain. So far, more than 200 sterols and related 
compounds have been identified.
1
 However, β-sitosterol 2 and campesterol 4 are 
predominant, comprising 95% of isolated phytosterols.
2
 
2 
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Figure 1. Structures of stigmasterol (1), β-sitosterol (2), stigmastanol (3), campesterol (4). 
 
In the past decades, phytosterols and their derivatives have been widely applied in 
different areas such as the food and cosmetic industries, and have recently received a lot 
of attention as nutraceutical additives.
3
 Because of their ability to lower the level of 
cholesterol  in the human body, phytosterols have drawn greater interest and have been 
widely used as food additives.
4
 Dietary intake of phytosterols is projected to increase in 
western countries as consumers respond to health messages to increase vegetable oil 
consumption at the expense of animal fats.
5
 Besides the nutraceutical application, 
phytosterols have also attracted attention as inhibitors of sarcoplasmic reticulum calcium 
ATPase and transportation through potassium ion channels.
6
 
 
As part of a collaboration investigating the structural influences of sterol ester structure 
on uptake and processing, I needed preparative amounts of pure β-sitosterol However, β-
sitosterol is commercially available in preparative amounts only as mixtures with other 
phytosterols, typically stigmasterol and campesterol. The few reported separations are 
3 
 
relatively laborious.
7
  We therefore became interested in the synthesis of sitosterol from 
stigmasterol, which is available in pure form.   Two routes have been reported for this 
conversion.  
 
The first route is illustrated in Scheme 1,
8
 and is based upon selective saturation of the 
sidechain (∆22-23) alkene. Selective hydrogenation of the side chain Δ22-23 alkene with 
Raney Nickel was found to produce β-sitosterol contaminated with the fully saturated 
stigmastanol. Since β-sitosterol and stigmastanol are very similar in size, shape, and 
polarity, it is very difficult if not impossible to isolate pure β-sitosterol from crude 
hydrogenation products.  However, treatment of the crude mixture of products with Br2 
resulted in conversion of the the Δ5-6 alkene in β-sitosterol to a dibromide 5, which can be 
separated from stigmastanol via column chromatography. Finally, the alkene group could 
be regenerated via Zn/AcOH reduction of the dibromide, producing β-sitosterol as a pure 
compound. 
HO
Raney Ni
HO
H2
+
HO
Br2
HO
Br
Br HO
Zn
EtOH/AcOH
1 2 3
5
2
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Scheme 1. Synthetic route to pure beta-sitosterol via dibromide 
 
The second route is illustrated in Scheme 2.
9
 This approach, which has been applied to 
the synthesis of β-sitosterol and related sterols, circumvents the need for selective 
hydrogenation by protecting the ∆5-6 alkene as a cyclopropyl carbinyl ether 7. Following 
hydrogenation of the ∆22-23 side chain double bond with Pd/C as catalyst, solvolysis of the 
cyclopropane reintroduces both the C3-alcohol and the ∆5-6 alkene.  Although this 
approach is very useful as a means of obtaining very pure samples of β-sitosterol, 
semipreparative applications were challenging in terms of removal of sterol methyl ether 
byproducts 8.  
 
HO
TsCl, Pyridine
DMAP
TsO
MeOH
+
MeO
OMe
Pd/C, H2
EtOH
OMe
HO
TsOH
Dioxane
1
6
7 8
9
2  
Scheme 2. Synthetic route to pure β-sitosterol via cyclopropyl carbinyl ether 
5 
 
 
As discussed in more detail below, we reinvestigated the hydrogenation of stigmasterol 
and developed an improved approach to sitosterol and sidechain-modified sitosterols 
based upon temporary protection of the A-ring alkene as an epoxide.     
 
2. Result and discussion 
 
2.1 Stigmasterol hydrogenation with Raney Nickel 
Raney nickel is a finely-divided gray powder which is composed of fine grains of a 
nickel-aluminum alloy. It was developed in 1926 by Murray Raney,
10
 and the original 
purpose is to catalyze the hydrogenation of vegetable oils in industrial processes. 
However, because of the special properties of massive irregular size pores in its three 
dimension structure and large Brunauer-emmett-Teller surface area,
11
 Raney nickel 
exhibit high catalytic activity, and has been widely used as a heterogeneous catalyst in 
organic synthesis.
12
 
 
Raney nickel is prepared when a block of nickel-aluminum alloy is treated with 
concentrated sodium hydroxide.
13
 The resulting reaction is shown in Equation 1.  
 
NiAl2  +  6NaOH Raney Nickel  +  2Na3AlO3  +  3H2 
Equation 1. Preparation of Raney Nickel 
 
6 
 
Fresh Raney Nickel was prepared according to standard procedure.
10
 Commercially 
available pure stigmasterol was used to test the selective hydrogenation efficiency with 
stoichiometric amount Raney Nickel (3 equiv.). Results were shown in Table 1. 
Hydrogenation of stigmasterol with Raney nickel could give a mixture of β-sitosterol and 
over reduced saturated stigmastanol. The ratio of these two compounds depends on the 
reaction times. However, as shown in Table 1, we found that reduction with Raney 
Nickel is not useful as a method to provide pure β-sitosterol (>95%).  
 
Reaction scale Time  Products 
(Stigmasterol : β-sitosterol : stigmastanol) 
1mmol 4h 4: 88: 8 
1mmol 6h 0 : 89 : 11 
1mmol 8h 0 : 85 : 15 
1mmol 24h 0 : 61 : 39 
Table 1. Hydrogenation of stigmasterol with Raney Nickel 
 
2.2 Stigmasterol hydrogenation with Rieke Nickel 
7 
 
Rieke metals are a type of highly reactive metal powders, which are prepared by the 
methods developed by Reuben D. Rieke.
14
  The reactivity of Rieke metals results from a 
very high surface area and the lack of surface oxides which retard reaction. Highly 
reactive Rieke metals are generally prepared by reducing metal salts in ethereal or 
hydrocarbon solvent, using alkali metals as reducing agents
15
 (Equation 2). Typical alkali 
metals used in this method are potassium, sodium, and lithium. Among the many metals 
that have been generated by this method are Mg, Ca, Ti, Fe, Co, Ni, Cu, Zn, and In.  
 
MXn  +  nK M  +  nKX 
Equation 2. Typical method of preparing Rieke Metal 
 
In some cases the reaction is carried out with a catalytic amount (5-10% mole percent) of 
an electron carrier such as biphenyl or naphthalene.
16
 During the reaction performance, 
the coprecipitated alkali metal salt is usually not separated from the highly reactive metal, 
which is generally used in situ. 
 
A recent study indicates that the selective hydrogenation of multiple carbon-carbon bonds 
could be promoted by Rieke Nickel particles.
17 
Selective hydrogenations of dienes are 
shown in Table 2. In the entry 4, the less hindered alkene in the side chain of (R)-
limonene was reduced while the trisubstituted alkene in the ring was not affected at all. 
Diene
NiCl2-Li-DTBB(cat.)-EtOH
THF, rt
Monoene
 
8 
 
Entry Starting diene T(h) Product Yield(%) 
1 
 
24 
 
95 
2 
 
21 
 
99 
3 
 
22 
 
88 
4 
 
22 
 
99 
Table 2. Selective hydrogenation of diene with Rieke Nickel.
17
 
 
We investigated the reduction of stigmasterol by Rieke Ni under conditions which could 
either allow direct reduction of the alkene by the Rieke Ni or could allow Ni-catalyzed 
hydrogenation (Table 3). Superstoichiometric Rieke nickel (3 equiv.) reacted with pure 
stigmasterol under an atmosphere of hydrogen at room temperature. However, no β-
sitosterol was obtained after the attempted reduction. Instead, only the starting material 
was recovered. 
9 
 
 
Nickel salt Reductant Electron carrier Result 
NiCl2 Li  DTBB (cat.) No reduction 
NiBr2 Li  Naphthalene (cat.) No reduction 
NiBr2 Mg - No reduction 
NiCl2 Mg - No reduction 
Table 3. Attempt of Rieke Nickel reduction 
 
2.3 Stigmasterol hydrogenation with platinum dioxide  
Platinum dioxide (PtO2), also known as Adams' catalyst, is a commercially available dark 
brown powder usually represented as platinum(IV) oxide hydrate, PtO2
.
H2O. It is widely 
used as a precursor to a useful catalyst for hydrogenation and hydrogenolysis in organic 
synthesis.
18
 In the reaction, the platinum dioxide itself is not an active catalyst. But as 
soon as this black powder is exposed in hydrogen gas, it will be converted to active black 
platinum metal, which is the real reductant and is responsible for reactions.  
 
PtO2 has been widely applied to the selective hydrogenation of dienes in many organic 
molecules. It was reported that PtO2 can catalyze the hydrogenation of (-)-perillyl alcohol 
10 
 
with high selectivity and high yield
19
 (Scheme 3). The less hindered terminal alkene can 
be reduced while the more hindered alkene remains unaffected. 
OH
PtO2
H2
OH
Yield 96%  
 Scheme 3. Selective hydrogenation of (-)-perillyl alcohol with PtO2.
21
  
 
A suspension containing a mixture of a catalytic amount of PtO2 and pure stigmasterol 
was reacted under an atmosphere of hydrogen (balloon) at room temperature to test the 
selectivity of hydrogenation. Results are shown in Table 4. We found that hydrogenation 
in the presence of PtO2 provides inseparable mixtures of unreacted stigmasterol, β-
sitosterol, and the saturated stigmastanol. The exception is for prolonged reaction, where 
the undesired stigmastanol becomes the only product.  
 
PtO2 % Solvent Result (Stigmasterol: β-sitosterol: stigmastanol) 
1 MeOH 85:15:0 
11 
 
1 EtOH 12:68:20 
5 EtOH 0:0:100 (48h) 
1 EtOAc 38:38:24 
Table 4. Hydrogenation of stigmasterol with PtO2 
  
2.4 Attempts to separate phytosterols by recrystallization.   
Recrystallization is a widely used procedure for purifying compounds and removing 
impurities, and it has been reported that β-sitosterol can be purified from a mixture of 
different sterols via recrystallization procedure
20
 (Table 5).  Our initial investigations 
employed a mixture of phytosterols obtained from our collaborator, Prof. Tim Carr (UNL 
Nutrition Sciences) and including mainly β-sitosterol (65%) and  α-sitosterol (19%). 
Recrystallization of 5g of this mixture in a solvent mixture of 20ml toluene, 15ml acetone 
and 2ml water increased the amount of β-sitosterol to approximately 93%, and other 
phytosterols were mainly removed.  
Before crystallization After crystallization 
β-sitosterol  
α-sitosterol 
Campesterol 
others 
64.8% 
19.0% 
5.5% 
10.7% 
β-sitosterol 
α-sitosterol 
Campesterol 
others 
93.3% 
1.5% 
4.9% 
0.3% 
Table 5. Recrystallization of sterols mixture. 
22 
12 
 
 
However, application of the same recrystallization conditions to 5 g of a sterol mixture 
derived from a Raney Nickel hydrogenation (70% β-sitosterol, 8% stigmasterol, and 22% 
stigmastanol)  provided a mixture of β-sitosterol (71%), stigmasterol (5%), and 
stigmastanol (24%). Similarly, recrystallization of a  commercial β-sitosterol sample from 
Acros (β-sitosterol 75%, campesterol 10%, and other undefined phytosterols 15%) 
provided a mixture of β-sitosterol (87%), campesterol (13%). Overall, our results 
demonstrate that it is not practical to obtain pure β-sitosterol from a sterols mixture by 
recrystallization. 
 
2.5 Synthetic route to pure β-sitosterol 
After experiencing disappointing results with both selective hydrogenation and 
recrystallization, I started to research new synthetic routes that could provide pure β-
sitosterol in amounts sufficient for use in animal feeding studies.  
 
2.5.1 Synthetic route involving McMurry reaction 
A retrosynthesis of a new route to sitosterol is shown in Figure 2. It starts with the 
reduction of  commercially available stigmasterol by Raney Nickel to give a mixture with 
β-sitosterol and stigmastanol. Then the Δ5-6 alkene of the β-sitosterol was cleaved via 
ozonolysis to the dicarbonyl compound, which would presumably be easily separated 
from unreacted stigmastanol by chromatography. Finally, the alkene would be reformed 
via the intramolecular McMurry reaction. 
13 
 
HO AcO
O
O
AcO AcO
Mixtrue with sigmastanol
Figure 2. Retrosynthesis analysis 
 
The McMurry reaction is an organic reaction in which two ketone or aldehyde groups are 
reductively dimerized to form an alkene. The reaction uses a reduced titanium reagent 
most often prepared from reaction of titanium(III) chloride and a reducing agent, often an 
alkali metal.
21
 This reductive coupling involves two steps. A radical coupling induced by 
single electron transfer to the carbonyl groups from alkali metal generates a 1,2-diol as a 
titanium alkoxide;  a subsequent deoxygenation of the 1,2-diol with low-valent titanium 
yields the alkene (Figure 3).  
 
 
Figure 3. McMurry reaction 
 
Our approach began with commercially available stigmasterol (Scheme 3). Raney nickel 
reduction produces an inseparable mixture of β-sitosterol (75%) and stigmastanol (25%) 
which was converted to the acetates. The mixture of acetates 10 and 11 was reacted with 
14 
 
ozone, followed by Zn/AcOH reduction. The dicarbonyl 12 derived from oxidative 
cleavage of β-sitosterol acetate was easily separated from the unreacted stigmastanol 
acetate. McMurry reaction was applied to the intermediate 12 under the condition of 
TiCl3 and K in THF refluxing. However, none of the desired β-sitosterol acetate 10 was 
obtained. 
HO
Raney Nickel
HO HO
75% 25%
Ac2O
Pyridine
AcO AcO
75%
25%
AcO
1) O3, CHCl3/MeOH = 9/1
2) Zn, H2O/AcOH = 1/9
1 2 3
10 11
12
yield 44%
O
O
AcO
10  
Scheme 3.  Synthesis of β-sitosterol  
 
It is possible that the failure resulted from the incompatibility of the acetate groups with 
the McMurry reagent. We therefore investigated the application of the McMurry reaction 
on substrates containing triethylsilyl ethers. As shown in Scheme 4, this approach was 
initially modeled on the mixture of triethylsilyl ethers derived from the mixture of 
sitosterol and stigmastanol. The mixture was treated with ozone, and the crude products 
15 
 
were reduced with PPh3 reduction to generate an easily separated mixture of dicarbonyl 
compound 14 and the unreacted stigmastanol ether.  It should be noted that a phosphine 
reduction was employed because the Zn/AcOH reduction employed in the previous 
example was anticipated to be incompatible with the triethylsilyl ether. A pure sample of 
14 was treated with typical McMurry reaction condition (TiCl3 and K). However, once 
again, the reaction failed to generate the desired sitosterol skeleton (13). 
HO TESO
TESCl, iPrNH2
DMAP, Et2O
1) O3, CHCl3/MeOH = 9/1
2) PPh3, Et2O
TESO
O
O
TESO
2
75% purity
13
75% purity
1413  
Scheme 4. Reaction attempts with TES protecting group 
 
2.5.2 Synthetic route involving epoxide intermediate 
We ultimately developed a successful synthetic route to pure β-sitosterol based on a 
sequence involving selective epoxidation of ∆5-6 alkene, hydrogenation of the sidechain 
alkene, and deoxygenation of the epoxide (Figure 4).  
16 
 
Figure 4. Retrosynthesis analysis 
 
Our approach was inspired by a recent study
22
 of epoxidation of cycloolefins by the t-
BuOH copper-permanganate system.  This study included an example of the selective 
oxidation of stigmasteryl acetate at ∆5-6 alkene, producing a mixture of 5α,6α-epoxide 
and 5β,6β-epoxide with the ratio β/α= 6/1 (Figure 5).  
AcO
Cu(MnO4)2
tBuOH-CH2Cl2 (3:1)
AcO AcOO O
 epoxide epoxide
 
Figure 5. Selective oxidation of stigmasterol acetate via Cu(MnO4)2 
 
However, if we were going to use an epoxide as an alkene protecting group, we would 
also require a mild method of regenerating the alkene.  Although a number of reagents 
have been reported for reductive deoxygenation of epoxides,
23
 most are relatively harsh. 
We became interested in a report describing the deoxygenation of epoxides at room 
temperature using aluminium triiodide.
24
   The deoxygenation is thought to involve an 
iodoalcohol intermediate (Figure 6).  
17 
 
O
R1
R2
R3
R4
AlI3
OH
R1
R2
R3
R4
I
R1
R2
R3
R4
I2
 
Figure 6. Reduction of epoxide with AlI3 
 
Based on the above reports, we developed a new synthesis of β-sitosterol as illustrated in 
Scheme 5. Cu(MnO4)2 was prepared in situ by reaction of KMnO4 and CuSO4. Selective 
epoxidation of the Δ5-6 alkene of stigmasterol acetate 15 with Cu(MnO4)2 formed a 6:1 
mixture of the 5β,6β-epoxide 16a and 5α,6α-epoxides 16b. The ratio of two isomers was 
determined by NMR (Figure 7). Hydrogenation of the mixture of 16a and 16b over Pd/C 
cleanly furnished a 1:6 mixture of stigmastanol epoxides 17a and 17b. Then 
deoxygenation of the saturated epoxides with AlI3 proceeded rapidly to furnish a good 
yield of β-sitosteryl acetate 10.  Saponification afforded pure β-sitosterol 2, with mp 134-
135 °C and [α]D = - 37, which matched very closely with literature values.
26
 
 
HO AcO
Cu(MnO4)2
tBuOH-CH2Cl2 (3/1)
Ac2O
Pyridine
AcO AcO
O O
1 15 16a 16b
Pd/C
H2 balloon
AcO AcO
O O
17a 17b
AcO
AlI3
HO
K2CO3
102
 
18 
 
Scheme 5. Synthesis of β-sitosterol 
 
 
Figure 7. 
1H NMR spectra of 5α,6α and 5β,6β-epoxide of stigmasteryl acetate 
 
I also investigated a variant of this route based upon epoxidation with the commercially 
available peracid m-chloroperbenzoic acid (mCPBA). The use of this oxidant also 
resulted in  regioselective oxidation of the ∆5-6 alkene, but now produced a 2.6:1 mixture 
of stigmasterol oxides favoring the α-isomer 16a. Hydrogenation proceeded uneventfully 
to furnish the corresponding mixture of sitosterol oxides 17a and 17b.  However, 
attempted deoxygenation under the same conditions as employed earlier (AlI3, 10 min, 
CH3CN/CH2Cl2) now furnished only 33% of β-sitosterol acetate 10, accompanied by a 
significant amount (estimated > 60% by mass) of a more polar product which yellowed 
immediately upon exposure to room light.  The formation of the byproduct could be 
19 
 
avoided almost completely by allowing the deoxygenation to proceed for 40 min. 
Alternatively, the byproduct could be converted to β-sitosterol acetate 10 by treatment 
with additional AlI3.  The results suggest that the deoxygenation of the α- and β-epoxides 
proceeds at very different rates, with the 5α, 6α-diastereomer 16a reacting via the 
intermediacy of a semistable iodohydrin.  I therefore focused on the use of the CuMnO4 
system for my studies.  
 
The ability to protect the ∆5,6-alkene of stigmasterol also suggested a facile means of 
preparing other sidechain-modified phytosterols. Phytosterols with sidechain-
modification have been important in studying phytosterol metabolism in human body.
25
 
Although methods have been reported for preparation of sidechain-modified phytosterol, 
26
 these synthetic routes are not efficient. Since the epoxide intermediates 16a and 16b 
are quite stable, we reasoned that they would be easily converted to the corresponding 
aldehydes via ozonolysis, allowing introduction of new side chains via Wittig or Julia 
chemistry (Figure 8).  
 
Figure 8. Strategy to prepare sidechain-modified phytosterols 
 
As an example of this methodology, we chose to convert stigmasterol to campesterol, 
using a Julia olefination for introduction of the campesterol sidechain.  The necessary 
20 
 
sulfone (22) was prepared as a single enantiomer as illustrated in scheme 6.
27
 Alkylation 
of (S, S)-pseudoephedrine isovalerylamide with 3-methylbut-3-enyl triflate led to the 
formation of hydroxyamide 19. Reduction of 19 with lithium aminotrihydroborate (LAB) 
gave the (S)-2,3-dimethylbutanol 20 with 90% ee. Then the alcohol 20 could be 
converted to sulfide 21 through Mitsunobu reaction.  Oxidation of 21 with molybdenum 
salt afforded  sulfone 22. 
 
NH
OH
N
OH
O
N
OH
O
HO
N
S S
N
S S
O
O
(NH4)6Mo7O24
.4H2O
H2O2, EtOH
18 19
20 21
22
Cl
O
NEt3
+
LDA
MeI
LAB
THF
N
S
SH
DIAD, PPh3
THF
 
Scheme 6. Preparation of enantiomerically pure sulfone intermediate. 
 
Ozonolysis of the mixture of 16a/16b furnished an approximately 1:6 mixture of 
aldehydes 23a and 23b. Julia-Kocienski olefination, using the sulfone 22, furnished 
exclusively the alkene corresponding to the monoepoxide of the Z-isomer of 
crinosterol.
28
 The Z-stereochemistry was assigned from the 10.6 Hz coupling constant for 
H22-H23. Finally, hydrogenation, followed by deoxygenation of the epoxide as before, 
furnished campesterol acetate 26 (Scheme 7).  
21 
 
  
Scheme 7.  Synthesis of campesterol acetate 
 
The selective formation of Z-alkenes is unusual in Julia-Kocienski couplings, since most 
of time this reaction produces E-alkenes as the final product. I therefore investigated the 
olefination of 16a,b with a model isobutyl sulfone 27 derived from isobutyl alcohol 
(Figure 8). This reaction also selectively furnished the Z-alkene; the lower selectivity (2:1) 
compared with that observed for the synthesis of 24a,b may reflect the reduced degree of 
steric encumbrance in this model system. The ability to readily prepare Z-isomers of 
phytosterols opens the door to a number of steroid analogs not available from synthetic 
routes based upon Claisen rearrangements of C22 allylic alcohols.
29
 
22 
 
 
Figure 8. Generality of Z-selective olefination 
 
Overall, the formation of beta-sitosterol has been achieved in 52% overall yield from 
commercially available stigmasterol using relatively simple chemistry and via easily 
purified intermediates. The core strategy, protection of the ∆5-6 alkene as an epoxide, 
holds potential for synthesis of other phytosterols, including Z-isomers of existing 
phytosterols.   
 
 
3. Experimental 
 
General Experimental Conditions 
All reagents and solvents were used as supplied commercially, except CH2Cl2 and THF, 
which were distilled from CaH2, and Na/benzophenone, respectively. All reactions were 
conducted under an atmosphere of N2 except where noted; “RBF” indicates round-bottom 
flask. Thin layer chromatography (TLC) was performed on 0.25 mm hard-layer silica G 
plates. Developed TLC plates were visualized with a hand-held UV lamp or by staining: 
1% ceric sulfate and 10% ammonium molybdate in 10% H2SO4 (general stain, after 
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charring); 1% N,N’-dimethyl-p-phenylenediamine solution in 1:20:100 acetic 
acid/water/methanol (specific for peroxides); Melting points are uncorrected. Unless 
noted, NMR spectra were acquired at 400 MHz (
1
H) or 100 MHz (
13
C) in CDCl3. IR 
spectra were recorded as neat films on a ZrSe crystal with selected absorbances reported 
in cm
-1
. Mass spectroscopy was conducted at the Nebraska Center for Mass Spectrometry. 
 
Raney Nickel preparation 
A solution of NaOH (12.6 g, 0.315 mol) in distilled water (50 ml) is cooled in an ice bath 
to 10℃.  Nickel-Aluminum alloy (10 g) was added to the stirred solution in small portion 
and at a rate to prevent the temperature from rising above 25℃.When the entire alloy has 
been added, the reaction mixture is allowed to heat until there is no gas from the solution. 
Stirring was stopped and the reaction mixture was allowed to settle.  After the aqueous 
supernatant was decanted. The residue was washed with distilled water for 20 times until 
it is neutral, and then the solid was washed with EtOH for 3 times and stored in EtOH for 
future use.  
 
Raney Nickel reduction 
To the stigmasterol (4.2g, 10mmol) in EtOAc 400 ml, Raney Nickel (5g) was added. 
Then the reaction mixture was stirred in room temperature under the H2 balloon at 1 atm 
overnight. The Raney Nickel was filtered through Celite, and the organic solvent was 
removed under vacuo to afford the crude product, which was analyzed by GC-MS. 
GC-MS conditions: injector 270℃, FID detector 300℃, oven 270℃ for 1min, ramp at 15℃
/min to 300℃ as final temperature. 
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Stigmasterol acetate (15) 
AcO
15  
Stigmasterol acetate was prepared as a white solid (97%, mp 138-140℃) by a variant of 
the procedure of Wang.
30
 Other physical data were identical to the literature.
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5α,6α- and 5β,6β-epoxides of stigmasterol acetate (16a, 16b) 
AcO
O
16a -isomer
16b -isomer  
A mixture of KMnO4 (10 g, 60 mmol) and CuSO4•5H2O (5 g, 20 mmol) was ground to a 
fine powder in a mortar and pestle. Water 0.5 mL was added, and the slightly wet mixture 
was transferred to the reaction flask. To the stirred suspension of this mixture in 25 mL 
CH2Cl2, compound 2 (2.12 g, 5 mmol) was added, followed by t-BuOH 2.5 mL. Reaction 
mixture reflux for 1 hour and then cool down. The reaction mixture was filtered through a 
silica pad, washed with ether. After evaporation the solvent, crude solid was 
recrystallized from methanol to give a white solid 1.59 g, overall yield 75%. NMR data 
indicates the product was a 1:6 mixture of epoxides 16a and 16b.
26
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5α,6α- and 5β,6β-epoxy sitosterol acetate (17a, 17b) 
AcO
O
17a -isomer
17b -isomer  
A 1:6 mixture of 17a and 17b (1.35 g, 3.0 mmol) was dissolved in EtOAc 150 mL. 10% 
Pd/C (0.32 g) was added, and reaction mixture stirred at room temperature under an 
atmosphere of H2 balloon for 12 hours. The reaction mixture was filtered through a Celite 
pad, and evaporated to a white solid (1.28 g, 96%) as a 1:6 mixture of epoxides 17a and 
17b.
32
  
 
Sitosterol acetate (10) 
AcO
10  
The mixture of epoxides 17a and 17b (470 mg, 1.0 mmol) was dissolved in 2:1 
CH3CN/CH2Cl2 30 mL. Aluminum triiodide was added (610 mg, 1.5 mmol) and the 
resulting mixture was stirred at room temperature for 10 minutes. The reaction was 
quenched with aq. 10% Na2S2O3 100 mL and the resulting mixture was extracted with 
CH2Cl2 (3 x 100 mL). The combined organic layers were dried over Na2SO4, and the 
residue from the concentrated filtrate was purified by flash chromatography 
(hexane/EtOAc, 95:5) to give 360 mg (80%) of sitosterol acetate 10 as a white solid. Mp 
111-112℃, [α]D = -34.5 (CHCl3). Other physical data were identical to the literature.
26
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β-Sitosterol (2) 
OH
2  
Sitolsterol acetate 10 (240 mg, 0.47 mmol) was dissolved in a mixture of 15 mL CH3OH 
and 15 mL CH2Cl2, K2CO3 (140 mg, 1 mmol) was added. Reaction mixture stirred at 
room temperature for 12 hours. Remove solvent under vacuum. The residue was 
extracted with 30 mL CH2Cl2 and 30 mL water. Combined organic layer dried over 
Na2SO4, filtered and evaporated. Crude solid was purified through flash chromatography 
(hexane/EtOAc, 80:20) to to give white solid 220 mg, yield 93%. Mp 134-135℃, [α]D = -
37 (CHCl3). Physical data was identical to the literature.
26
 
 
(S)-2,3-Dimethylbutan-1-ol (20) 
HO
20  
(S)-2,3-Dimethylbutan-1-ol 20 was prepared as a colorless liquid, overall yield 60%, [α]D 
= 4.4 (CHCl3), by the procedure of Tietze from (+)-(1S,2S)-Pseudoephedrine. Other 
physical data were identical to literature values.
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(S)-2-(2,3-dimethylbutylthio)benzothiazole (21) 
27 
 
N
S S
21  
To a mixture of 20 (102 mg, 1 mmol), 2-mercaptobenzothiazole (183 mg, 1.1 mmol) and 
PPh3 (288 mg, 1.1 mmol) in freshly distilled THF (4 mL) was added DIAD (0.21 mL, 1.1 
mmol) dropwise at 0℃  under argon. After being stirred for 3 hours at the same 
temperature, the reaction was quenched by water. The aqueous layer was extracted with 
EtOAc (10mL x 3 ). The combined organic layer was dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. Flash chromatography (hexane/EtOAc, 99:1) afforded 
thioether 21 (228 mg, 91%) as a light yellow oil. [α]D = 42.3 (CHCl3); IR 2957, 1455, 
1426, 1057, 991, 752 cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ7.89 (d, J= 8.06 Hz, 1H), 
7.75 (d, J= 8.06 Hz , 1H), 7.42 (t, J= 7.19 Hz, 1H), 7.29 (t, J= 7.19, 1H Hz), 3.50 (dd, 
J=12.66 Hz, 4.84 Hz, 1H), 3.18 (dd, J= 12.65Hz, 8.18 Hz, 1H), 1.88-1.77 (m, 2H), 1.04 
(d, J=6.67 Hz, 3H), 0.99 (d, J= 6.56 Hz, 3H), 0.94 (d, J= 6.56 Hz, 3H); 
13
C NMR (100Hz, 
CDCl3): δ167.75, 153.38, 135.15, 125.99, 124.08, 121.44, 120.91, 38.87, 38.78, 31.62, 
20.37, 17.96, 15.29; HRMS (m/z) [M-H]
+
 calcd for C13H18NS2
+
: 252.0881, found: 
252.0875 
 
(S)-2-(2,3-dimethylbutylsulfonyl)benzothiazole (22) 
N
S S
O
O
22  
A solution of 21 (183 mg, 0.73 mmol) in EtOH (10 mL) was oxidized with ammonium 
heptamolybdate tetrahydrate (1.8 g, 1.46 mmol) and 30% H2O2 (2.5 mL, 21.9 mmol) at 0℃ 
28 
 
for 2 hours. The mixture was extracted with EtOAc (10 mL x 3). The combined organic 
extracts were washed with brine (10 mL x 3), dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. Flash chromatography (hexane/ EtOAc, 90:10) afforded sulfone 
22 (177mg, 86%) as a pale yellow oil. [α]D = 15.5 (CHCl3); IR 2961, 1470, 1324, 1140, 
1085, 758 cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ8.23 (d, J= 7.92, 1H), 8.03 (d, J= 7.92, 
1H), 7.68-7.59 (m, 2H), 3.59(dd, J= 14.36, 3.54Hz, 1H), 3.31(dd, J= 14.11, 8.95Hz, 1H), 
2.29-2.19(m, 1H), 1.82-1.73(m, 1H), 1.10(d, J= 6.89Hz, 3H), 0.89(d, J= 6.80Hz, 3H), 
0.85(d, J= 6.89Hz, 3H); 
13
C NMR (100Hz, CDCl3): δ166.66, 152.70, 136.74, 128.00, 
127.67, 125.43, 122.38, 58.83, 38.68, 32.47, 19.23, 17.89, 15.93; HRMS (m/z) [M-H]
+
 
calcd for C13H18NO2S2
+
: 284.0779, found: 284.0778 
 
5α,6α-and 5β,6β-epoxides of (3β,20R)-3-acetyloxy-pregnane-20-carboxaldehyde (23a, 
23b) 
O
AcO
O
23a -isomer
23b -isomer  
A solution of 16a, 16b (100 mg, 0.21 mmol) in 10 mL of 50/50 CH2Cl2/MeOH was 
ozonolyzed at -78℃ for 5 minutes, then solvent was removed under vacuum. Residue 
was dissolved in 10 mL of 10/90 H2O/AcOH, Zinc powder (55 mg, 0.84 mmol) was 
added, and reaction mixture stirred for 2 hours at room temperature. 50 mL CH2Cl2 was 
added. Organic layer was washed with water (25 mL x 3), then dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. Flash chromatography (hexane/ EtOAc, 
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90:10) afforded white solid (81mg, 99%) as 1:6 mixture of epoxides 23a and 23b. IR: 
2950, 1727, 1367, 1262, 1238, 1042, 783cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ 9.57 (d, 
J= 3.29 Hz, 0.76H, b), 9.55 (d, J= 3.3 Hz, 0.16H, a), 4.99-4.91 (m, 0.14H, a), 4.81-
4.73(m, 0.87H, b), 3.09(d, J= 2.23Hz, 0.88H, b), 2.90 (d, J= 4.18Hz, 0.13H, a), 2.38-
2.31(m, 1H), 2.13-1.82(m, 9H), 1.54-0.89(m, 20H), 0.7(s, 3H); 
13
C NMR (100Hz, 
CDCl3): δ204.95, 170.52, 71.25, 63.41, 62.48, 55.39, 51.05, 50.93, 49.42, 42.89, 39.43, 
37.95, 36.67, 35.06, 32.41, 29.74, 27.17, 26.97, 24.54, 21.84, 21.30, 17.03, 13.40, 12.11; 
HRMS (m/z) [M-Li]
+
 calcd for C24H36LiO4
+
: 395.2774, found: 395.2778 
 
5α,6α- and 5β,6β-epoxides of (3S,10S,13R,17R)-17-((2R,5S,Z)-5,6-dimethylhept-3-en-2-
yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (24a, 24b) 
AcO
O
24a -isomer
24b -isomer  
To sulfone 22 (62 mg, 0.22 mmol) in 5 mL THF was added LiHMDS (0.22mL, 1M in 
THF, 0.22 mmol) dropwise at -78℃ and stirred for 1 hour. Aldehyde 23a and 23b (85 
mg, 0.22 mmol) was added in 5 mL THF. Stirring was continued for 1 hour, and reaction 
was gradually warmed to room temperature. The reaction was quenched by 15 mL water. 
The aqueous layer was extracted with EtOAc (10 mL x 3), then dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. Flash chromatography (hexane/ EtOAc, 95:5) 
afforded white solid (90 mg, 90%) as 1:16 mixture of epoxides 24a and 24b. IR: 2950, 
2867, 1743, 1368, 1037, 764cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ5.02(dd, J= 10.96, 
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9.88 Hz, 2H), 4.83-4.73(m, 1H), 3.09(d, J=2 Hz, 0.95H, b), 2.91(d, J=4.4 Hz, 0.06, a), 
2.43-2.33(m, 1H), 2.21-1.80(m, 9H), 1.68-0.83(m, 31H), 0.69(s, 3H); 
13
C NMR (100Hz, 
CDCl3): δ170.56, 135.13, 131.22, 71.34, 63.58, 62.52, 56.27, 56.02, 51.02, 42.18, 39.72, 
38.32, 38.01, 36.68, 35.04, 34.48, 33.35, 32.43, 29.74, 28.32, 27.20, 24.15, 21.92, 21.34, 
20.55, 20.36, 19.94, 18.63, 17.06, 12.06; HRMS (m/z) [M-H]
+
 calcd for C30H49O3
+
: 
457.3682, found: 457.3668 
 
5α,6α-and 5β,6β-epoxides of campesterol acetate (25a, 25b) 
AcO
O
25a -isomer
25b -isomer  
The mixture of epoxides 24a and 24b (30mg, 0.07 mmol) was dissolved in 5mL EtOAc. 
10% Pd/C (7 mg) was added, and reaction mixture stirred at room temperature under an 
atomphere of H2 balloon for 12 hours. The reaction mixture was filtered through a Celite 
pad, and evaporated to a white solid (28mg, 94%) as 1:9 mixture of epoxides 25a and 
25b. IR: 2953, 2867, 1729, 1367, 1263, 1043, 784cm
-1
; 
1
H NMR (300 MHz, CDCl3): δ
5.01-4.93(m, 0.15H, a), 4.83-4.73(m, 0.96H, b), 3.09(d, J=2.07 Hz, 0.9H, b), 2.90(d, J= 
4.35 Hz, 0.1H, a), 2.12-1.8(m, 8H), 1.58-0.77(m, 37H), 0.65(s, 3H); 
13
C NMR (75Hz, 
CDCl3): δ170.54, 71.34, 63.58, 62.51, 56.19, 56.14, 50.97, 42.28, 39.78, 38.81, 38.01, 
36.66, 35.82, 35.03, 33.65, 32.47, 32.41, 30.26, 29.73, 28.14, 27.21, 24.18, 21.92, 21.31, 
20.19, 18.66, 18.24, 17.03, 15.37, 11.76; HRMS (m/z) [M-H]
+
 calcd for C30H51O3
+
: 
459.3838, found: 459.3820 
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Campesterol acetate (26) 
AcO
26  
The mixture of epoxides 25a and 25b (28 mg, 0.06 mmol) was dissolved in 2:1 
CH3CN/CH2Cl2 (3 mL).  Aluminum triiodide was added (37 mg, 0.09 mmol) and the 
resulting mixture was stirred at room temperature for 30 minutes. The reaction was 
quenched with aq. 10% Na2S2O3 (10 ml) and the resulting mixture was extracted with 
CH2Cl2 (3 x 10 mL). The combined organic layers were dried over Na2SO4, and the 
residue from the concentrated filtrate was purified by flash chromatography 
(hexane/EtOAc, 95:5) to give 24mg (91%) of campesterol acetate 26 as a white solid. Mp 
130-131℃, [α]D = -32 (CHCl3); IR 2954, 1730, 1367, 1247, 1037, 735cm
-1
; 
1
H NMR 
(400 MHz, CDCl3): δ5.39(d, J=4.77Hz, 1H), 4.66-4.58(m, 1H), 2.33(d, J=7.87Hz, 2H), 
2.05(s, 3H), 1.90-1.84(m, 2H), 1.59-0.78(m, 38H), 0.68(s, 3H); 
13
C NMR (100Hz, 
CDCl3): δ170.56, 139.66, 122.66, 73.99, 56.69, 56.08, 50.02, 42.31, 39.73, 38.84, 38.12, 
36.99, 36.59, 35.90, 33.70, 32.43, 31.90, 31.86, 30.27, 28.24, 27.78, 24.29, 21.46, 21.03, 
20.22, 19.32, 18.70, 18.26; HRMS (m/z) [M-Na]
+
 calcd for C30H51O2Na
+
: 465.3709, 
found: 465.3703 
 
2-[(2-Methylpropyl)sulfonyl] benzothiazole (27) 
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                            27 
Compound 27 was prepared using the same procedure with benzothiazole 22. Mp 44-
45℃. Other physical data were identical to the literature.33 
 
Model reaction of 27 with 16a,b 
 
The reaction procedure was the same with the formation of 24a,b. Yield (88%). IR: 2953, 
2869, 1740, 1355, 1053cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ5.28(dd, J=15.3, 6.4 Hz, 
0.35H, trans-alkene), 5.16 (dd, J=15.3, 8.1Hz, 0.36H, trans-alkene), 5.02(dd, J=8.15, 2.61, 
0.63H, cis-alkene), 4.98(dd, J=8.14, 2.94Hz, 0.62H, cis-alkene), 4.81-4.72(m, 1H), 
3.09(d, J=2 Hz, 0.95H, β-isomer), 2.91(d, J=4.4 Hz, 0.06, α-isomer), 2.66-2.54(m, 1H), 
2.48-2.37(m, 1H), 2.23-1.67(m, 9H), 1.58-0.89(m, 29H), 0.69(s, 2H), 0.66(s, 1H); 
13
C 
NMR (100Hz, CDCl3): δ170.55, 134.91, 134.24, 133.97, 133.49, 71.33, 63.66, 62.52, 
58.26, 56.04, 51.01, 42.19, 39.82, 39.71, 38.00, 36.67, 36.05, 34.52, 32.44, 30.92, 29.73, 
33 
 
28.34, 28.27, 27.20, 26.80, 24.16, 23.58, 23.14, 22.75, 21.91, 21.32, 21.10, 17.05, 12.07, 
11.97; HRMS (m/z) [M-Na]
+
 calcd for C28H44O3Na
+
: 451.3188, found: 451.3194 
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Chapter 2. Study of phytosterol ester and phytosterol ether metabolism mechanism 
(Portions of the material included in this chapter have been published. Brown, A. W., 
Hang, J. Dussault, P. H., Carr, T. P. Phytosterol ester constituents affect micellar 
cholesterol solubility in model bile, Lipids 2010, 45, 855; Brown, A. W., Hang, J., 
Dussault, P. H., Carr, T. Sterol and stanol substrate specificity of pancreatic cholesterol 
ester lipase, J. Nutr. Biochem. 2010, 21, 736) 
 
 
2.1 Introduction 
In the United States, cardiovascular disease is the leading cause of death over the last two 
decades, and now accounts for over 25% of all deaths each year.
34
 These cardiovascular 
diseases are often linked with chronic kidney disease and hypercholesterolaemia, 
especially the high concentration of cholesterol in low-density lipoprotein (LDL).
35
 A 
lipoprotein is a protein that exists as an aggregate or complex including a substantial 
number of fats and lipids.  Lipoproteins transport fats and lipids in the bloodstream, 
providing a means for fats to move through a water-rich environment. The five major 
classes of proteins are classified according to their density (Table 1). Low-density 
lipoprotein (LDL) has the highest concentration of cholesterol (50%) of any lipoprotein 
and increased levels of LDL have been associated with increased risk of cardiovascular 
disease.  Therefore, the goal in many pharmaceutical and nutraceutical therapies is to 
decrease LDL concentration in the human body. One of the most successful nutraceutical 
approaches to reducing LDL levels is through consumption of free plant sterol or sterol 
esters.
36
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Density(g/ml
) 
Class %protei
n 
%cholestero
l 
%phospholipi
d 
%triacylglycer
ol 
>1.063 HDL 33 30 29 4 
1.019-1.063 LDL 25 50 21 8 
1.006-1.019 IDL 18 29 22 31 
0.95-1.006 VLDL 10 22 18 50 
<0.95 Chylomicron
s 
<2 8 7 84 
Table 1. Classification of lipoprotein.
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The mechanism by which phytosterol consumption decreases LDL has not been clarified 
yet. A recent study suggested that phytosterols could decrease the incorporation of 
cholesterol into intestinal micelles, thus reducing cholesterol absorption and increasing 
excretion of cholesterol.
38
 Besides free phytosterols, phytosterol esters are found to show 
similar ability to decrease the concentration of cholesterol. As dietary additives, both free 
phytosterols and phytosterol esters are shown to be effective in displacing cholesterol. 
However, using in-vitro models, only free phytosterols have the same ability.
39
 This 
observation suggests that the phytosterol esters must be hydrolyzed in the digestive tract 
to generate phytosterols which can be subsequently micellarized and absorbed. The 
enzyme pancreatic cholesterol esterase (PCE) is the likely agent  responsible for the 
36 
 
hydrolysis of phytosterol esters.
40
 PCE, an ester hydrolase with broad substrate 
specificity,
41
 has showed important functions in the intestine, including controlling the 
bioavailability of cholesterol from dietary cholesterol esters and contributing to 
incorporation of cholesterol into mixed micelles.
42
   
 
Collaborating with Dr. Carr research group (UNL Department of  Nutrition and Health 
Sciences), we studied the mechanisms why consumption of phytosterols and phytosterol 
esters could decrease the LDL concentration, and examined the effect of simulated 
phytosterol esters hydrolysis products concentration on micellar cholesterol solubility in a 
model bile system. Our role in this collaboration was the preparation of phytosterol esters 
and ethers.  
 
2.2 Results and discussion 
Preparation of phytosterol esters 
As illustrated in scheme 1, phytosterol esters were prepared via the reaction between free 
sterol and acid chloride, respectively. Each phytosterol ester was prepared on a 120 gram 
scale.  
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Scheme 1. Synthesis of phytosterol esters 
 
Preparation of phytosterol octadecyl ether 
The Carr group had formulated a hypothesis that the free phyotosterol, generated upon 
hydrolysis of phytosterol esters within the intestine, is able to displace cholesterol from 
micelles.  In order to demonstrate that the micellar effect results from the free sterols and 
not the esters, we were interested in molecules that were structural analogs of the 
phytosterol esters but would not undergo hydrolysis by PCE or similar enzymes.  We 
therefore prepared octadecyl ethers of the phytosterol on 120 gram scale (scheme 2).  
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Scheme 2. Synthesis of phytosterol octadecyl ether. 
 
While there are numerous methods for making short-chain ethers of sterols, particularly 
cholesterol,
43,44
 there are few reports describing synthesis of long-chain ethers. Zhang 
reported the alkylation of cholesterol in the condition of dodecyl bromide, sodium 
hydride and THF solvent afforded the cholesteryl dodecyl ether with 29% yield in the 5 
gram scale.
45
 However, it is difficulty to apply this method to 120 gram scale preparation, 
which could not use column chromatography as the purification tool. In order to 
overcome this problem, I screened different reaction conditions for phytosterol octadecyl 
ether synthesis in preparative reaction (Table 1). In the solo THF solvent, this reaction 
requires as much as 8 eq. alkyl iodide to complete starting sterol, with an isolation yield 
about 56% (Entry 1 and 2). If 18-crown-6 was added to reaction mixture to help the 
alkoxy anion more soluble in THF solvent, this reaction will furnish at 50% conversion 
of sterol (Entry 3). However, if the mixture solvent system THF/DMF(3/1) was used, the 
conversion and  isolation yield will increase significantly (Entry 4, 5, and 6). Considering 
the atomic efficiency and affordable isolation yield, reaction ratio of 2 eq. alkyl iodide, 2 
eq. sodium hydride was used to prepare phytosterol octadecyl ether, which could be 
purified by recrystallization from hot ethyl acetate. 
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Entry phytosterol (eq.) C18H37I (eq.) NaH (eq.) Solvent Yield 
1 1 2 2 THF <20% form TLC 
2 1 8 8 THF 56% (10g scale) 
3 1 (with 1eq. 18-
crown-6) 
2 2 THF Conversion 50% 
from TLC 
4 1 4 4 THF/DMF(3/1) 60% (10g scale) 
5 1 4 8 THF/DMF(3/1) 57% (10g scale) 
6 1 2 2 THF/DMF(3/1) 45% (50g scale) 
Table 1. Reaction conditions screen for synthesis of phytosterol octadecyl ether. 
 
Summary of investigations of: 1) influence of the phytosterols and phytosterol esters 
on micellarization of cholesterol; and, 2) the role of phytosterol ester or ether 
structure on the acctivity of pancreatic cholesterol esterase. This part of research was 
performed by Andrew Brown (PhD, 2011) in the research group of Dr. Tim Carr in the 
UNL Department of Nutrition and Health Sciences.  
 
1) The presence of an equal amount of stigmasterol, β-sitosterol or stigmastanol 
decreases the cholesterol solubility in micelles by approximately 50%. The results 
indicate stigmasterol is more effective than β-sitosterol and stigmastanol in displacing 
cholesterol. Andrew Brown also compared different fatty acids to simulate the 
byproducts of ester hydrolysis of fatty esters.  Unsaturated fatty acids increased the 
40 
 
micelle solubility of sterols compared with saturated fatty acids or no fatty acids, and the 
result does not depend on the size of model micelles. Finally, an in vivo study indicates 
that the combination of stigmasterol and saturated fatty acids is the most effective for 
lowing cholesterol micelle solubility.  They also demonstrated that in vivo models, both 
free and esterified esters could lower the cholesterol concentration in micelles, which 
confirms the sterol esters must be firstly hydrolyzed to impart the cholesterol-lowering 
properties. The detailed results are reported in Brown, A. W., Hang, J., Dussault, P. H., 
Carr, T. J. Nutr. Biochem. 2010, 21, 736. 
 
2) Pancreatic cholesterol esterase hydrolyzes palmitate, oleate and stearate esters of 
cholesterol, stigmasterol, stigmastanol and β-sitosterol. The rate of hydrolysis was 
dependent on both the sterol and the fatty acid moieties in the following order: 
cholesterol > β-sitosterol = stigmasterol >stigmastanol; oleate > palmitate = stearate. The 
addition of free phytosterols to the system did not change hydrolytic activity of 
pancreatic cholesterol esterase, while addition of palmitate, oleate or stearate increased 
activity. The detailed results are reported in: Brown, A. W., Hang, J. Dussault, P. H., Carr, 
T. P. Lipids 2010, 45, 855 
 
2.3 Experimental Section 
Stigmasterol (95%) was purchased from TCI America. β-Sitosterol (75%) was purchased 
from ACROS Organics. Stigmastanol (95%) was prepared via hydrogenation of 
stigmasterol.
46
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Synthesis of phytosterol esters (illustrated for β-sitosteryl palmitate): 
Palmitoyl chloride (30 g, 0.11 mol) were added dropwise to a stirred mixture of β-
sitosterol (30 g, 0.072mol) and dimethylaminopyridine (2.4 g, 0.021 mol) in 100 ml of 
dry pyridine and 400 ml of dry chloroform at room temperature, and stirred overnight. 
The reaction was diluted with 1L of water. The resulting suspension was acidified to a pH 
of 3–4 with 3 M HCl and subsequently extracted with three washes of 500 ml of 
dichloromethane. The combined organic layers were dried over sodium sulfate and 
solvent was removed under reduced pressure. The residue was recrystallized from hot 
ethyl acetate to furnish sitosteryl palmitate (44 g, 88% yield) as a white solid (mp 79–
80°C). Other physical data were identical to literature reports.
47
 Analysis by 1H NMR 
suggested the sitosteryl palmitate was 92% pure and contained approximately 8% of a 
mixture of stigmasteryl and stigmastanyl palmitates. The experiment was performed in 
three batches to collect 120 g phytosterol ester. 
 
Other phytosterol esters were prepared with the similar procedure (Table 2).  
Phytosterol ester Yield % 
Stigmasterol palmitate 92 
β-Sitosterol palmitate 89 
Stigmastanol palmitate 93 
Stigmasterol stearate 94 
β-Sitosterol stearate 88 
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Stigmastanol stearate 90 
Stigmasterol oleate 83 
β-Sitosterol oleate 85 
Stigmastanol oleate 79 
Table 2. Preparation of phytosterol esters. 
 
Synthesis of phytosterol octadecyl ether 
To a commercial mixture of phytosterol (50 g, 0.10 mol; contains β-sitosterol 75%, 
campesterol 10%), tetrahydrofuran (500 ml) and dimethylformamide (160 ml), sodium 
hydride (11 g, 0.25 mol; sodium hydride 60% dispersion in mineral oil was washed with 
hexane for three times) was added slowly at 0°C. After no evolution of gas, the reaction 
mixture then refluxed for 1 hour. The reaction was allowed to cool to r.t., and octadecyl 
iodide (91 g, 0.24 mol) was added. Then reaction mixture was refluxed for 12 hours. 
Tetrahydrofuran was removed under vacuum, and the residue was extracted with ether 
(200 ml) three times. The combined ether layer was dried over Na2SO4, filtered, and 
concentrated to afford crude product. Recrystallization from hot ethyl acetate furnished 
phytosterol octadecyl ether, mp 67- 68 °C (30 g, 45%).  This experiment was performed 
in four batches to collect 120 g phytosterol octadecyl ether. 
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Chapter 3 
A new peroxide fragment: generation of singlet oxygen from 1,1-dihydroperoxide 
and its derivatives 
(Portions of the material included in this chapter have been published.  Jiliang Hang, 
Prasanta Ghorai, Solaire A. Finkenstaedt-Quinn, Ilhan Findik, Emily Sliz, Keith 
T.Kuwata, and Patrick H. Dussault; Generation of Singlet Oxygen from Fragmentation of 
Monoactivated 1,1-Dihydroperoxides; J. Org. Chem, 2012, 77, 1233.) 
 
 
 
We reported that monoactivated derivatives of 1,1-dihydroperoxides undergo a 
previously unobserved fragmentation to generate high yields of singlet molecular oxygen 
(
1
O2). 
 
3.1 Introduction 
Oxygen, represented by the symbol O, is an element with atomic number 8 and molecular 
weight 16. It is one of the most abundant elements on the earth and comprises about 21% 
in the atmosphere, 89% in seawater, 47% in Earth’s crust and 60% in the human body.  In 
nature, one simplest but most important substance that contains oxygen element is 
oxygen gas (O2), which is composed by two oxygen atoms. This colorless, odorless, and 
tasteless gas plays an important role for almost all living organisms, it is essential for 
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energy generation and respiration. Nowadays, oxygen has been widely applied in many 
different industries, including steel manufacturing, chemical processing, metal fabrication, 
petroleum refining, and etc.
48, 49
 
 
The electronic configuration for ground state oxygen is 
(1σs)
2(1σs
*
)
2(2σs)
2(2σs
*
)
2(2σp)
2(2πx)
2(2πy)
2(2πx
*
)
1(2πy
*
)
1
. This ground state is triplet (
3Σg
-
) 
and paramagnetic because of two parallel electronic spins. Except for the two electrons at 
the antibonding 2πx
*and 2πy
*
orbitals, all other molecular orbitals are fully occupied. For 
the excited state of oxygen, there are two different singlet states, 
1Δg and 1Σg
+
 (Figure 1).  
 
Figure 1. Electronic configurations of oxygen molecular in ground and excited states. 
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The 
1Δg state is 22 kcal/mole higher in energy compared with the ground state. The 
radiative lifetime is 45 minutes at very low gas pressure and 10
-6
 – 10-3 s in solutions. The 
1Σg
+
 excited state, is 37 kcal/mole above the ground state and the radiative lifetime is 7 
seconds and 10
-11
 – 10-9 s in solutions.50,51 The energy diagram is illustrated in Figure 2. 
In condensed materials, for example reaction solvents, the high energy excited state 
O2(
1Σg
+
)  rapidly converts to the low energy excited state O2(
1Δg).
52
 Therefore, the 
“singlet oxygen” or “singlet O2” is generally referred to the 
1Δg state. Only the 
1Δg 
oxygen is believed to be involved in organic transformations.  
 
Figure 2. Energy diagram for oxygen molecule 
 
Generation of singlet oxygen (
1Δg) 
Since high excited state singlet oxygen (
1Σg
+
) can be converted to low excited state (
1Δg) 
rapidly in condensed material,  most generation methods can be considered to create the 
1Δg state of singlet oxygen. In the past decades, researchers have developed two major 
types of generation methods, photosensitization and chemical generation. Both of these 
two methods can be used generate 
1
O2 in preparative amounts.  
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Photosensitized production of singlet oxygen 
Photosensitization is a light-activated process, which requires a light-absorbing 
photosensitizer, which is often a dye or natural pigment. Photosensitization is the most 
convenient method for singlet oxygen generation. As shown in Figure 3, a sensitizer 
absorbs the light in a specific wavelength region and is converted to an electronically 
excited state (sensitizer
*
). Then, the energy transfer from the sensitizer
*
 to the oxygen 
(
3Σg
-
), produces singlet oxygen and regenerating the sensitizer. The scheme is 
oversimplified, as the spin selection rules for the excitation require a triplet state of the 
sensitizer* in order to achieve excitation of the triplet ground state of oxgen. Depending 
upon the excited state energy of the sensitizer*, both O2(
1Σg
+
) and O2(
1Δg) may be formed 
by the energy transformation. However, the conversion from O2(
1Σg
+
) to O2(
1Δg) occurs 
spontaneously with extremely high rate constant in condensed mediums. As a result, only 
O2(
1Δg) will be generated from photosensitization. 
 
Figure 3. Generation of 
1
O2 by photosensitization 
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A lot of dyes and pigments have been used as photosensitizers, such as Rose Bengal, 
methylene blue, porphyrins and phthalocyanines (Figure 4). Different light sources have 
also been used in this process, including medium-pressure sodium lamp, tungsten lamp, 
xenon and mercury lamps.
53
 Due to side reaction of peroxide decomposition, ultraviolet 
light is not generally used for photosensitization. Since visible light has more than 
enough energy to create a sensitizer
*
,  it is the common light source for these 
photosensitizers. 
 
Figure 4. Structure of some photosensitizers 
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The singlet oxygen quantum yield is a key property for a photosensitizer. It is defined as 
the number of molecules of 
1
O2 molecules generated for each photon absorbed by a 
photosensitizer. The quantum yields of some photosensitizer are listed in Table 1. 
Photosensitizer Solvent 
1
O2 quantum yield 
2-Acetonaphthone C6H6 0.71 
Benzophenone C6H6 0.36 
Acridine C6H6 0.83 
Rose Bengal H2O 0.76 
Methylene Blue CH3OH 0.51 
Tetraphenylporphine C6H6 0.66 
(BuO)8ZnPc C6D6 0.47 
Table 1. Singlet oxygen quantum yield of some photosensitizer.
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Chemical generation of singlet oxygen 
Chemical sources for singlet oxygen generation are quite diverse. Many different 
chemical reactions have been developed to produce singlet oxygen. Most of these 
reactions need the water-enriched media. The first developed reaction was based upon the 
reaction of sodium hypochlorite  with H2O2, which produces 
1
O2 in nearly quantitative 
yield.
55
 Phosphite ozonides, which are produced by reaction of ozone with phosphite, can 
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generate 
1
O2 by decomposition. 
56
 Many other methods have also been reported, based 
upon decomposition of ozone,
57
 hydrogen peroxide, 
58
 hydrotrioxides,
59
 and some 
inorganic peroxides.
60
 Generation of 
1
O2 in organic solvent has been achieved through 
thermal decomposition of calcium peroxide,
61
 arene endoperoxides,
62
 phosphite 
ozonides,
63
 silyl hydrotrioxides,
64
 and alkyl hydrotrioxides.
65
 Major classes of reaction 
for chemical generation of 
1
O2 are overviewed in Figure 5. 
 
Figure 5. Chemical generation of singlet oxygen 
 
However, the current methods for chemical generation of 
1
O2 have some drawbacks. The 
first one is that most reactions require water-enriched media. 
1
O2 has a very short lifetime 
in aqueous media. The second one is that when applying these reactions for preparative 
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purposes, many substrates do not trap 
1
O2 efficiently, so that a large excess of reagent 
must be used to obtain appreciable substrate conversion. 
 
In addition to these chemical sources, a number of other reactions have been found to 
produce singlet oxygen in biological systems.
66
 Some enzymatic systems have been 
suggested to give singlet oxygen. However, most of these sources are still under 
investigation.  
 
Chemical reaction of singlet oxygen 
Singlet oxygen is a very useful reagent, which could allow the stereoselective and 
regioselective introduction of dioxygen into organic molecules. It can react with many 
organic compounds, including olefins, dienes, arenes, and sulfide. The reactions with 
alkenes are most common, and can be divided into three classes: [4+2] cycloadditions 
with 1,3-dienes, [2+2] cycloadditions and ene reactions with isolated double bonds.  
 
 [4+2] Cycloaddition with singlet oxygen 
In a reaction that appears similar to a Diels-Alder reaction, singlet oxygen can react with 
cis-1,3-dienes for form the 6-member endoperoxides. It was once suggested that this 
reaction had the same concerted pathway just like the Diels-Alder reaction. However, 
recent studies indicates that, the perepoxide intermediate in a stepwise process would 
have a lower energy compared with the transition state in concerted pathway.
67
 Therefore, 
the stepwise pathway has been suggested, and in this pathway, the formation of 
perepoxide intermediate would be the rate-determining step (Figure 6).  
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Figure 6. Possible reaction pathway for singlet oxygen [4+2] cycloaddition 
 
1,3-butadienes which undergo [4+2] cycloadditions with 
1
O2 can be classified into 5 
different categories: nonhomoannular 1,3-diene, alkenylarenes, homoannular aliphatic 
dienes, heterocyclic 1,3-dienes and nonheterocyclic aromatic dienes. These types of 
substrates and their reaction products are shown in Figure 7.
 68
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Figure 7. Examples of singlet oxygen reaction with dienes 
 
The 
1
O2 [4+2] cycloaddition reaction to endoperoxide product has many applications. 
This reaction has been widely used as key steps in total synthesis of many natural 
products, such as Ricciocarpin B (Figure 8).
69
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Figure 8. Application of [4+2] cycloaddition in synthesis of Ricciocarpin B 
 
Ene reaction with singlet oxygen 
The ene reaction is a type of chemical reaction between an alkene with an allylic 
hydrogen (the ene) and a compound containing a π-bond (the enophile), in order to form 
a new σ-bond. The version of this that involves a carbon-carbon bond as an enophile is 
called an Alder-ene reaction. In the transformation, the double bond of the ene shifts and 
new Y-H and C-X σ-bonds are formed (Figure 9). 
 
Figure 9. Ene-reaction 
 
The ene reaction with singlet oxygen was firstly discovered by Schenk in 1943.
70
 In this 
reaction, the alkene with allylic hydrogen substrate is oxidized by singlet oxygen to 
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generate an allylic hydroperoxide, where both double bond and allylic hydrogen have 
shifted. Study of the mechanism has suggested a stepwise mechanism involving an 
intermediate perepoxide (Figure 10).
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Figure 10. Mechanism of singlet oxygen ene reaction 
 
In the ene reaction, the double bond always shifts to the allylic position, and formation of 
the new C-O bond and removal of the hydrogen occurs on the same face of the π system 
(suprafacial), and leads to formation of the trans olefin as a major product (Figure 11).
 72
  
 
Figure 11. Suprafacial selectivity of singlet oxygen ene reaction 
 
The allylic hydroperoxides products of the ene-reaction are important intermediates, and 
can undergo a number of different organic transformations (Figure 12). 
73
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Figure 12. Examples of transformation from allylic hydroperoxides 
 
[2+2] Cycloaddition with singlet oxygen 
Beside the ene reaction, singlet oxygen can also react with olefins to form products 
derived from a [2+2] cycloaddition process. The [2+2] cycloaddition with singlet oxygen 
is usuallly disfavored compared with the ene reaction.
74
 However, the [2+2] 
cycloaddition will be the dominant if the olefin substrates are extremely electron-rich or 
if the substrates lack accessible allylic hydrogens.  (Figure 13).  
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Figure 13. Competence between [2+2] cycloaddition and ene reaction 
 
Similar with ene reaction, the [2+2] cycloaddition of alkenes with singlet oxygen is a 
stepwise process involving a perepoxide intermediate.  Rearrangement of the perepoxide 
intermediate generates 1,2-dioxetane product (Figure 14).  
 
Figure 14. Mechanism of [2+2] cycloaddition with singlet oxygen 
 
Detection of singlet oxygen 
Detection of singlet oxygen can be achieved by luminescence (Figure 15). There are two 
types of luminescence from singlet oxygen, the direct “monomol” phosphorescence at 
1270 nm,
75
 and the “dimol” emission at 630 and 701 nm.76  
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Figure 15. Luminescence from singlet oxygen 
 
The detection at 1270 nm luminescence has become the standard technique for 
investigation of singlet oxygen photochemistry. The lifetime of singlet oxygen in most 
solvent systems is ranges from a few microseconds to milliseconds, this luminescence 
therefore is very weak, and results a low quantum yield from roughly 10
-6
 to 10
-3
. To 
observe the luminescence at 1270 nm, specialized detectors has been developed. In the 
past decades, the germanium diode detector has been developed as a routine 
measurement of this luminescence.
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The singlet oxygen “dimol” luminescence arises from collision between two molecules of 
singlet oxygen and gives rise to a quantum of twice the energy of the monomol, with 
emission at 630 and 710 nm. Since this emission requires two molecules, its intensity is 
related to singlet oxygen concentration. 
 
Chemical trapping of singlet oxygen 
A lot of organic compounds can react with singlet oxygen to give the “fingerprint” 
products. Therefore, these chemicals could be used as the chemical trapping reagents in 
situ for singlet oxygen in the biological or other systems. Most trapping reagents react 
58 
 
with singlet oxygen through [4+2] reaction or ene reaction. . Some common trapping 
agents are shown in figure 16.  α-terpinene, diphenyl isobenzofuran and 9,10-
diphenylanthracene. 
 
Figure 16. Examples of trapping reagents for singlet oxygen 
 
In addition to these traditional trapping reagents, some new reagents have been developed. 
A recent study reported a new anthracene derivative which could be used as a singlet 
oxygen trapping reagent via the fluorescent probe (Figure 17).
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Figure 17. anthracene derivative trapping reagent. 
 
Application of singlet oxygen 
Because of its special activity, singlet oxygen has been widely used in many areas. One 
major application is the photodynamic therapy, which is used clinically to treat a wide 
range of medical conditions.
79
 In photodynamic therapy, a photosensitizer is used and 
absorbs energy from a light source. Then the energy will transfer to the molecular oxygen 
in human tissue and create an excited state oxygen molecule, singlet oxygen. Ultimately, 
singlet oxygen will react rapidly with nearby biomolecules, which could kill cancer cells. 
Another important application of singlet oxygen is to be the source of chemical oxygen 
iodine laser.
80
 The excited singlet oxygen transfers energy to iodine molecule, then the 
excited iodine undergoes simulated emission and radiates as laser. 
 
3.2 Result and discussion 
In the previous investigation of a “reductive ozonolysis” of alkene, singlet oxygen could 
be generated during rearrangement of the intermediate.
 81
 This transformation was 
hypothesized to involve nucleophilic addition of amine N-oxides to short-lived carbonyl 
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oxides to generate peroxyanion/oxyammonium acetals. These previously unknown 
intermediates were surmised to undergo fragmentation to generate the observed 
“reduction” products, along with a molecule of singlet oxygen, and a molecule of amine 
(Eq. 1). A similar fragmentation should be possible for any species featuring a geminal 
relationship between a peroxyanion and a heterolytically activated O-X bond. Previous 
study revealed the reactivity of monoperesters of readily available 1,1-dihydroperoxides. 
Deprotonation of these species resulted in rapid fragmentation accompanied by highly 
efficient liberation singlet oxygen (Eq. 2). 
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The next section will discuss our investigations of generations of singlet oxygen through 
decomposition of derivatives of 1,1-dihydroperoxides. 
 
Range of acetal/ketal scaffolds 
I firstly investigated the scaffolds of 1,1-dihydroperoxide substrates. A series of 1,1-
dihydroperoxides (1a-8a) were prepared through Re(VII)-promoted peroxyacetalization 
of the corresponding ketones (Scheme 1).
83
 Monoacetylation with acetic anhydride and 
pyridine furnished isolable monoperesters (1b-4b, 6b, and 7b). The exception was 
adamantanone dihydroperoxide (5a), which underwent ring expansion to a lactone upon 
61 
 
attempted acylation. 1,1-Dihydroperoxides derived from aldehydes reacted to form 
highly polar byproducts products, presumably resulting from E1cb fragmentation of 
peresters bearing an adjacent C-H. 
 
Scheme 1.  Synthesis of 1,1-dihydroperoxides and derived monoperesters 
 
Thermal stability 
Dihydroperoxide 1a, which melts without decomposition at 78-80 °C and is not 
detonated by a sharp hammer blow, undergoes a highly exothermic decomposition when 
heated beyond 100 °C. Monoacetate 1b, is stable for prolonged periods at freezer 
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temperature and for days at room temperature, but the onset of an exothermic 
decomposition is observed at approximately 76 °C. Monocarbonate 1d undergoes partial 
decomposition within days at room temperature to form a substituted caprolactone and 
undergoes exothermic decomposition when heated above 70 °C (Figure 18). 
 
 
 
                              1a                                                                     1b  
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                             1d 
Figure 18. Thermal stability of 1a, 1b, 1d 
 
Assay for 
1
O2 
Based on the synthesized substrates, the assay for 
1
O2 was tested. The release of 
1
O2 was 
quantified by chemical reaction with terpinene (T) or diphenylisobenzofuran (DPBF, D).  
Terpinene undergoes addition of 
1
O2 to form the stable endoperoxide ascaridole (T-O2 Eq. 
3). DPBF undergoes an even more rapid addition to generate diketone D-O2 via an 
unstable endoperoxide (Eq. 4).  T-O2 and D-O2 are easily quantified through isolation or 
by NMR or GC/MS analysis in the presence of an internal standard.  
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Variation of the bisperoxyacetal skeleton: 
I next investigated the generality of the fragmentation across a range of peroxyacetal 
skeletons.  Solutions of monoesters 1b-4b, and 6b-8b were decomposed with TBAF in 
the presence of 0.5 equiv of terpinene (Table 2); the relative stoichiometry was chosen to 
facilitate product separation. Addition of base was accompanied by the disappearance 
(TLC) of the monoesters and the appearance of the corresponding ketone and ascaridole 
(T-O2). The yield of trapped 
1
O2 varied little with structural variations in the peroxyacetal. 
By comparison, a 1,1-dihydroperoxide (1a) did not react under the reaction conditions.  
 
monoperester or diOOH yield T-O2 
a
 
1b 26% 
2b 26% 
3b 23% 
4b 31% 
5b 27% 
7b 24% 
8b 23% 
1a NR 
a
Yield of T-O2 relative to monoperester 
Table 2. Influence of scaffold on reactivity 
OOAc
OOH n-Bu4NF (1.2 eq)
CH3CN (r.t.), 0.08h
T (0.5 eq) T-O2+
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Influence of peroxyacetal backbone on relative reactivity 
Curious as to the influence of peroxyacetal structure on the relative rate of the reaction, I 
investigated the decomposition of mixtures of dihydroperoxide monoesters in the 
presence of a limiting amount of TBAF. The results, illustrated in Scheme 3, demonstrate 
very little difference in reactivity between acyclic and cyclic substrates (1b and 4b) or 
between cyclic substrates possessing different amounts of ring strain (7b and 1b).   
 
Scheme 3. Influence of peroxyacetal backbone 
 
Influence of Solvent 
Singlet oxygen has different lifetime in various solvents (Table 3). The lifetimes are 
typically 30-100 µs in organic solvents, and could increase to several hundred 
microseconds in deuterated organic solvents. In perfluorinated solvent, singlet oxygen 
has longest lifetime.  
Solvent Lifetimes (µs) Slovent Lifetime (µs) 
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H2O 3.8 Acetone 50 
D2O 62 d6-Acetone 723 
CH3OH 10 CH3CN 62 
Hexane 31 CD3CN 554 
CH2Cl2 86 C5H5N 16 
CHCl3 264 C6H5CH3 27 
CDCl3 740 C6D5CD3 320 
C6H6 30 Freon-113 15800 
C6D6 630 C6F6 3900 
Table 3. Lifetime of singlet oxygen in various solvents.
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Decomposition of monoester 1b in a number of solvent systems (Table 4) revealed the 
yield of dioxygen transfer (T-O2) to be increased in solvents associated with greater 
1
O2 
lifetime as evidenced by a comparison reaction in CDCl3 vs. CHCl3. The exception was 
for perfluorinated media, in which reaction appeared limited by reagent solubility. 
However, improved yields were possible in fluorocarbon/CH3CN mixtures. 
 
Solvent Base Yield T-O2 
a
 
CH3CN n-Bu4NF 26% 
CHCl3 n-Bu4NF 17% 
CDCl3 n-Bu4NF 35% 
Acetone-d6 n-Bu4NF 33% 
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C6D6 n-Bu4NF 30% 
C6F6 n-Bu4NF 7 %
b
 
C6F6 KOtBu 1 %
b
 
C6F6/ CH3CN (9:1) n-Bu4NF 24 % 
C6F6/ CH3CN (1:1) n-Bu4NF 36 % 
C6F14/ CH3CN (1:1)
c
 n-Bu4NF 28 % 
Freon-113/CH3CN (1:1) n-Bu4NF 39 % 
a
Yield of T-O2 based upon 1b; 
b
Limited reagent solubility; 
c
biphasic 
Table 4. Influence of different solvents 
 
Order of addition 
In early experiments involving decomposition of monoperester 1b,
36
 the  yield of 
1
O2 was 
observed to sometimes depend upon the order of addition of KOtBu and perester, 
suggesting the possibility of disproportionation to form poorly reactive bisperesters (vida 
infra).
 
 However, I reinvestigated this phenomenon using peracetate 1b and TBAF and 
found an insignificant difference (Table 5). 
 
Conditions Yield T-O2 
Add nBu4NF to solution of 1b and T 35% 
Add 1b to solution of nBu4NF to and T 38% 
Table 5. Influence of order of addition of reagents 
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Range of activating groups 
Base-promoted decomposition of a perbenzoate (1c) and a percarbonate (1d) proceeded 
rapidly to furnish yields of trapped 
1
O2 similar to those observed for the peracetate (1b) 
(Table 6).  Attempts to prepare the analogous percarbamate or persulfonate led only to 
ring-expansion.  
 
Reagent Yield of 1c or 1d Yield T-O2 
a
 
PhCOCl 1c (37%) 24% 
EtOC(O)Cl 1d (76%) 20% 
PhNCO decomp - 
TsCl decomp - 
a
Based upon T-O2 vs. stoichometry of 1c or 1d 
Talbe 6. Investigation of other peracyl activating groups 
 
Influence of Base/Counterion 
The preliminary work had observed rapid decomposition of the dihydroperoxide 
monoesters in the presence of KOtBu, TBAF, or Cs2CO3, but not K2CO3 or KHCO3 and 
we decided to further investigate the importance of the counterion. As shown in Table 7, 
comparing the decomposition of 1b in the presence of LiN(TMS)2 resulted in much lower 
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yields of 
1
O2 trapping compared to reactions involving the comparably basic KOtBu or 
TBAF. 
 
Base Yield T-O2 
a
 
KOtBu 30% 
LiN(SiMe3)2 (in THF) 4.1% 
nBu4NF (in THF) 35% 
a
relative to stoichometry of perester 
Table 7. Investigation of different bases 
 
Effect of temperature and rate of addition:   
We then want to look at the effect of temperature and the rate of addition. Not 
surprisingly, the TBAF-promoted decomposition of monoperester 1b was observed (TLC) 
to proceed significantly faster at higher temperatures; however, the yield of trapped 
1
O2 
was improved at lower temperatures (Table 8, entries 1-4). The base-promoted 
decomposition of the 1,1-dihydroperoxide monoesters is rapid; for example, rapid (1-2 
sec) injection of 1M THF solution of TBAF into a rapidly stirring solution of monoester 
1a (1M in THF) results in immediate effervescence.  However, a slow rate of addition 
was associated with a significant increase in the yield of trapped 
1
O2 (entries 5 and 6). 
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Entry 
T 
(°C) Solvent 
Reaction time 
(h) 
Mixing time 
(h)
 
yield T-O2 
c 
1 rt THF 0.25 10
-3 
10% 
2 0 THF 0.25 10
-3
 13% 
3 - 40 THF 0.25 10
-3
 19% 
4 - 78 THF 0.25 10
-3
 24% 
5 rt CH3CN 0.25 3 x 10
-4 
24% 
6 rt CH3CN 0.25 0.25 42% 
a 
nominally 1M in THF. 
b
Single injection or timed delivery from syringe pump.  
c
Yield 
T-O2 relative to perester 
Table 8. Influence of temperature and rate of addition 
 
Attempted gas-phase transfer 
The inverted relationship between the yield of oxygen transfer and the rate of substrate 
decomposition (Table 8, entries 5 and 6) led me to investigate whether 
1
O2 could be 
escaping into the gas phase. A septum-covered flask was charged with an acetonitrile 
solution of perester 1b and the head space was exhausted via a short Teflon tube into an 
acetonitrile solution of terpinene (Figure 19). Rapid (≤ 10 sec) addition of TBAF/THF 
into the solution of monoester 1b led to vigorous effervescence and net efflux of a high 
volume of gas through the receiving solution.  However, no significant amount of 
ascaridole (T-O2) was detected.  
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Figure 19. Gas-phase transfer attempt of singlet oxygen generation 
 
Generation of the peroxyanion via nucleophilic desilylation 
I investigated an alternative route to the presumed peroxyanion intermediate through 
nucleophilic desilylation. Monotrialkylsilylated substrates were readily available via 
silylation of the monoesters (Scheme 4).  Curiously, the signal corresponding to the 
perester carbonyl remained invisible by 
13C NMR despite use of pulse delays (≥ 5 sec) or 
the addition of Ni(acac)2 as a relaxation agent.
85
 The peracyl carbon could be observed as 
a single sharp signal at 167.8 ppm for spectra acquired at ≤ 40 °C (9a, 9b, 11).  However, 
this phenomenon was not encountered with either the monoperesters (e.g. 1b) or a 
bisperester (16).  
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Scheme 4. Synthesis of silylated peresters 
 
Reaction of the silylated monoesters with TBAF in the presence of a trapping agent 
resulted in yields of transferred 
1
O2 equal to or exceeding those observed through 
deprotonation of the dihydroperoxide monoesters (Table 9).  
 
 
Subs SiR3 t (min) Trap Yield
a 
9a SiEt3 5 D 33% 
9b TBS 5 D 29% 
9b TBS 5 T 25% 
9b TBS 10 D 25% 
10 SiEt3 30 D 34% 
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11 SiEt3 20 D 37% 
12 SiEt3 10 D 41% 
13 SiEt3 16 D 38% 
14 SiEt3 5 D 28% 
a
Yield of T-O2 or D-O2 relative to peroxide starting material. 
Table 9. Frgamentation of silylated dihydroperoxide monoesters 
 
Reactivity of bissilyl and bisacyl derivatives of a 1,1-dihydroperoxide 
Preparation of bissilyl and bisacyl derivatives of dihydroperoxide 1a are illustrated in 
Scheme 5. The bistriethylsilyl derivative (15) was an oily compound that decomposed at 
~ 140 °C.  The bisacyl derivative (16) was a solid that melted without decomposition at 
54-56 °C.  Saponification of 16 with cesium hydroxide in CH3CN resulted in reformation 
of the parent ketone and generation of 
1
O2. 1,1-Dihydroperoxide 1a was unreactive 
towards base; the derived bissilyl ether (15) was decomposed by nBu4NF without 
apparent transfer of oxygen.  
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Scheme 5. Reactivity of bissilyl and bisacyl derivatives of 1,1-dihydroperoxides 
 
Tandem activation and fragmentation 
Intrigued by the possibility of generating and decomposing the monoactivated 
bisperoxide intermediate in situ, I inverstigated the reactivity of dihydroperoxide 1a with 
four classes of reagents anticipated to form an activated derivative: an electron-poor 
nitrile, a heteroaromatic known to undergo SNAr reaction with tertiary hydroperoxides, a 
sulfonyl chloride, and an acid anhydride. The initial assay qualitatively monitored the 
formation of ketone upon addition of base to solutions containing both the 1,1-
dihydroperoxide 1a and the additive (Table 10).   In each case, the addition of 
stoichometric electrophile and excess KOtBu resulted in rapid conversion of the 1,1-
dihydroperoxide to 4-tert-butylcyclohexanone without any evidence of intermediates. 
Although these reactions should in theory require only two equivalents of base, I found 
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that four equivalents were invariably required to achieve complete consumption of the 
dihydroperoxide.    
 
Activator KOtBu 
(eq) 
t (h) Convs
a 
CCl3CN 2.0 0.75 incomplete 
CCl3CN 4.0 ≤ 0.1 complete 
triazene 2.0 >12 incomplete 
triazene 4.0 ≤ 0.1 complete 
p-TsCl 2.0 0.3 incomplete 
p-TsCl 4.0 ≤ 0.1 complete 
Ac2O 2.0 0.5 incomplete 
Ac2O 4.0 0.25 complete 
a
Consumption of 1a (TLC, NMR) 
Table 10. Investigation of electrophiles for activation/fragmentation 
 
Then I reinvestigated the most promising conditions in the presence of a trapping agent. 
The yields of oxygen transfer were similar regardless of activating agent and proved to be 
as good or better as those obtained with the dihydroperoxide monoesters (Table 11).   
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Activator t (min) Yield D-O2 
a 
CCl3CN 5 36% 
triazene 5 39.5% 
p-TsCl 5 39% 
Ac2O 5 31% 
a
 relative to dihydroperoxide 1a 
Table 11. Oxygen transfer via in-situ activation 
 
Preparative Reactions 
I investigated the amount of reagent necessary to completely consume a trapping reagent 
using either the fragmentation of a preformed perester (1b, 8b) or the tandem 
activation/fragmentation of dihydroperoxide 1a.  As illustrated in Table 12, complete 
consumption of terpinene could generally be achieved with as little as 5 equiv of reagent.   
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Subs (eq) Trap Reagents (eq) t (min) Product ( yield
a
 ) 
1b (5) T TBAF (5) 10 T-O2 (83%) 
1b (6) T TBAF (6) 10 T-O2 (100%) 
1b (2.5) D TBAF (2.5) 5 D-O2 (100%) 
1a (5) T triazine (5), KOtBu (20) 15 T-O2 (69%) 
1a (7) T triazine (7), KOtBu (28) 15 T-O2 (100%) 
8b (6) T TBAF (6) 10 T-O2 (100%) 
a
 yield of T-O2 or D-O2 
Table 12. Investigation of preparative conditions 
 
Reaction order and apparent rate constant 
To gain information about the reaction rate and order, I followed the base-promoted 
decomposition of monoperbenzoate 1c at 272 nm (Figure 20). In the first experiment, 
rapidly stirred THF solutions (0.5 mM) of dihydroperoxide monoester 1c in a cuvette 
were mixed with a series of THF solutions of TBAF ranging in concentration from 0.5 to 
2.00 mM. The reaction solutions were then placed in the UV spectrophotometer, and the 
absorbance at 272 nm monitored for 1.0 minute.  Plotting the log of the initial 
concentration of TBAF against the negative log of the change in absorbance revealed an 
apparent reaction order of 0.94 in TBAF and a calculated rate constant of 10
2
 L/mol-sec. 
Repeating the experiment with a constant concentration of TBAF and varying 
concentrations of 1c indicated an order of 1.2 in peroxide and a calculated rate constant 
of 10
2
 L/mol-sec.  Overall, the results support a mechanism that is first-order in both 
peroxide and base.   
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Figure 20. Monitoring rate of decompositions 
 
Theoritical investigations 
Collaborators Dr. Kuwata and his group in Macalester College finished the theoretical 
study of this new fragmentation.  
The base-promoted fragmentation of the monoactivated 1,1-dihydroperoxides could 
conceivably involve a concerted Grob-like fragmentation. B3LYP/6-31+G(d,p) 
calculations suggest a concerted fragmentation to offer the lowest energy pathway for 
generation of 
1
O2 and a carbonyl. The alternative pathway is disfavored both by the strain 
in the trioxetane intermediate, presumably reflecting electron pair repulsions, as well as 
by the high barrier for loss of 
1
O2 (Figure 21). The detailed results were reported in J. Org. 
Chem, 2012, 77, 1233. 
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Figure 21. Theoretical study of fragmentation of the monoactivated 1,1-
dihydroperoxides 
 
Discussions 
This reaction constitutes a new class of fragmentation involving a peroxyanion geminally 
linked to an electrophilically activated peroxide (Figure 22). The peroxyanion 
intermediate can be generated by deprotection, nucleophilic desilylation, or deacylation, 
but it must be highly dissociated. The data from competition reactions suggests that 
deprotonation may be rate limiting. 
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Figure 22. Mechanistic overview 
 
The ability to achieve tandem activation and fragmentation of readily available 1,1-
dihydroperoxides is noteworthy. Hydroperoxyimidates, while not isolable, have been 
postulated as short-lived intemediates in epoxidations.
86
 Peroxytriazenes, which have 
been prepared from SNAr reactions of tertiary hydroperoxides, have mainly been of 
interest as radical sources.
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The observation of more efficient oxygen transfer in deuterated or halogenated solvents is 
not surprising given the enhanced lifetime 
1
O2 in solvent lacking C-H, O-H, or N-H 
bonds. The failure of the results to scale linearly to 
1
O2 lifetime results from the fact that 
the trapping substrate is by definition a potent quenching agent. However, the observation 
of an inverted relationship between the rate of fragmentation and the yield of trapped 
1
O2 
remains perplexing. The lifetime of 
1
O2 in organic solvent varies little with temperature.
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The reaction of 
1
O2 with electron-rich alkenes has a near-zero enthalpy of activation and 
a strongly negative entropy of activation;
89
 photosensitized oxygenations are often quite 
rapid even at low temperature. The observations of lower trapping yields at higher 
reaction rates suggest quenching or loss of 
1
O2. However, there is no evidence of either 
1
O2 escape into the gas phase nor any luminescence or other evidence of dimol 
quenching.
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3.3 Experimental Section 
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Standard procedure for preparation of 1,1-dihydroperoxide (illustrated for 1a) 
To a stirred room temperature solution of 4-tert-Butylcyclohexanone (0.50 mmol) and 
Re2O7 (0.025 mmol, 5 mol%) in CH3CN (typically 3 mL, but up to 8 mL in the case of 1h) 
was added 50% aqueous H2O2 (112 µL, 2.0 mmol). Following consumption of ketone 
(TLC), the reaction mixture was passed through a plug of silica, which was washed with 
EtOAc. Following partial concentration in vacuo, the residue was purified by flash 
column chromatography to give a white solid 1a. 
HOO OOH
1,1-Dihydroperoxy-4-tert-butylcyclohexane (1a): 84%, white solid, mp 81-
83°C, Rf = 0.33 (30% EA/Hex), other physical data were identical to literature reports.
41
 
 
HOO OOH
1,1-Dihydroperoxycycloheptane (2a): 83%, white solid, mp 59-61°C, Rf = 0.33 
(30% EA/Hex), other physical data were identical to literature reports.
 41
 
 
HOO OOH
1,1-Dihydroperoxycyclooctane (3a): 58%, colorless oil, Rf = 0.33 (30% 
EA/Hex),  other physical data were identical to literature reports.
 41
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HOO OOH
4-Phenyl-2,2-dihydroperoxybutane (4a): 72%, white solid, mp 61-
63°C, Rf = 0.36 (40% EA/Hex),  other physical data were identical to literature reports.
41
 
 
OOH
OOH
 1,1-Dihydroperoxyadamantane (5a): 88%, white solid, mp 148-150°C, Rf = 
0.30 (30% EA/Hex), other physical data were identical to literature reports.
41
 
 
HOO OOH
 5,5-Dihydroperoxynonane (6a): 75%, colorless oil. Rf = 0.25 
(20% EA/Hex), other physical data were identical to literature reports.
41
 
HOO OOH
1,1-Dihydroperoxy-3-tert-butylcyclopentane (7a): 84%, colorless oil. Rf = 
0.30 (30% EA/Hex),  IR:  3420, 2956, 2870, 1365, 1104, 963 cm
-1
; 
1
H   9.83 (s, 
2H), 2.05 (m, 2H), 1.9 (m, 2H), 1.7 (m, 2H), 1.47 (m, 1H), 0.85 (s, 9H); 
13
C NMR  
121.7, 49.2, 34.5, 32.6, 31.5, 27.4, 25.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for 
C9H18NaO4 (M+Na)
+
: 213.1103; found 213.1110 
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OOH
OOH
1,1-Dihydroperoxycyclododecane (8a): 93%, colorless oil, Rf = 0.33 (30% 
EA/Hex),  other physical data were identical to literature reports.
41
 
 
Standard procedure for preparation of 1,1-dihydroperoxide monoacetate 
(illustrated for 1b): 
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (1.48 g, 7.2 mmol) in 
CH2Cl2 (15 mL), was added DMAP (0.09 g, 0.75 mmol), and pyridine (0.57 g, 7.2 mmol). 
The reaction mixture was cooled to 0 
o
C and a solution of Ac2O (0.74 g, 7.2 mmol) in 
CH2Cl2 (10 mL) was added dropwisely over 10 min. Upon completion of addition, the 
reaction was stirred for 30 min at 0 °C, and then diluted with CH2Cl2 (100 mL). The 
solution was washed with saturated NaHCO3 (20 mL), water (20 mL), brine (20 mL), and 
then dried over anhydrous Na2SO4. The residue obtained upon removal of the solvent in 
vacuo was purified by silica flash chromatography (5% EA/Hex) to give a white solid 
(1.47 g, 84% yield). 
The acid anhydride could be replaced by acid chloride (peresters) or ethoxycarbonyl 
chloride (percarbonates) without any other change. 
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HOO OOAc
1-Acetyldioxy-1-hydroperoxy-4-tert-butylcyclohexane (1b): 84%, white solid, 
mp 35-37°C. Rf = 0.33 (10% EA/Hex); other physical data were identical to literature 
reports.
40
 
 
HOO OOAc
 1-Acetyldioxy-1-hydroperoxycycloheptane (2b): 76%, colorless oil. Rf = 0.33 
(10% EA/Hex); IR: 3345, 2930, 2859, 1756, 1425, 1171, 1006, 899 cm
-1
; 
1  
10.13 (s, 1H), 2.09 (2, 3H), 1.92 (m, 4H), 1.54 (br, 8H); 
13
C NMR  171.7, 117.4, 32.5, 
29.6, 22.6, 17.5; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C9H16NaO5 (M+Na)
+
: 
227.0895; found 227.0898 
 
HO O OOAc
 1-Acetyldioxy-1-hydroperoxycyclooctane (3b): 73%, colorless oil. Rf = 0.33 
(10% EA/Hex); IR: 3340, 2924, 1756, 1409, 1200, 1078, 898 cm
-1
 ; 
1  10.13 (s, 
1H), 2.15 (s, 3H), 2.00 (m, 2H), 1.89 (m, 2H), 1.63 (br, 4H), 1.57 (br, 6H); 
13
C NMR  
171.7, 116.8, 27.8, 27.4, 24.9, 21.8, 17.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for 
C10H18NaO5 (M+Na)
+
: 241.1052; found 241.1046 
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HOO OOAc
4-Phenyl-1-acetyldioxy-1-hydroperoxybutane (4b): 86%, colorless 
oil. Rf = 0.33 (10% EA/Hex); IR: 3340, 2988, 2900, 1758, 1378, 1066, 899, 748, 698 cm
-
1; 
1
H NMR  10.39 (s,1H), 7.35 (m, 2H), 7.28 (m, 3H), 2.86 (m, 2H), 2.24 (dd, J = 5.46, 
12.9 Hz, 1H), 2.20 (s, 3H), 2.09 (dd, J = 5.46, 12,2 Hz, 1H), 1.61 (s, 3H); 
13
C NMR  
171.7, 141.0, 128.6, 128.4, 126.3, 113.7, 34.9, 30.2, 18.1, 17.6; HRMS (ESI, MeOH/H2O, 
NaOAc), calc. for C12H16NaO5 (M+Na)
+
: 263.0895; found 263.0899 
 
HOO OOAc
  5-Acetyldioxy-5-hydroperoxynonane (6b): 76%, colorless oil. 
Rf = 0.33 (10% EA/Hex); IR: 3350, 2960, 2873, 1760, 1198, 1056, 899 cm
-1
; 
1
H NMR  
10.13 (s, 1H), 2.12 (s, 3H), 1.73 (m, 2H), 1.56 (m, 2H), 1.34 (m, 8H), 0.90 (t, J = 7.15 Hz, 
3H); 
13
C NMR  171.6, 116.0, 28.9, 25.6, 22.7, 17.4, 13.8; HRMS (ESI, MeOH/H2O, 
NaOAc), calc. for C11H22NaO5 (M+Na)
+
: 257.1365; found 257.1361 
 
HOO OOAc
1-Acetyldioxy-1-hydroperoxy-3-tert-butylcyclopentane (7b): 84%, colorless 
oil. Rf = 0.33 (10% EA/Hex); IR: 2959, 2869, 1758, 1365, 1184, 1070, 962; 
1
H NMR  
10.516/10.501 (two s, totaling 1H), 2.17 (s, 3H), 2.0 (m, 4H), 1.75 (m, 2H), 1.54 (m, 1H), 
0.88 (s, 9H); 
13
C NMR  171.6, 122.9, 122.8, 49.3, 49.2, 34.6, 34.5, 32.7, 32.6, 31.6, 
27.38, 27.36, 25.6, 17.6; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C11H20NaO5 
(M+Na)
+
: 255.1208; found 255.1199 
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HOO
OOAc
1-Acetyldioxy-1-hydroperoxycyclododecane (8b): 81% colorless oil. Rf = 
0.33 (10% EA/Hex);. IR: 3307, 2946, 2851, 1748, 1426, 1190, 997, 850 cm
-1
; 
1
H 
 10.22 (s, 1H), 2.17 (s, 3H), 1.76 (m, 2H), 1.59(m, 6H), 1.39 (br, 14H); 13C 
NMR  171.7, 116.8, 26.1, 25.9, 25.8, 22.1, 21.8, 19.3, 17.7; HRMS (ESI, MeOH/H2O, 
NaOAc), calc. for C14H26NaO5 (M+Na)
+
: 297.1678; found 297.1679 
 
HOO O O Ph
O
1-Benzoyldioxy-1-hydroperoxy-4-tert-butylcyclohexane (1c), 37%, 
white solid, mp 76-78 °C, Rf = 0.43 (10% EA/hex), other physical data were identical to 
literature reports.
40
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HOO O O OEt
O
4-tert-Butyl-1-hydroperoxycyclohexyl ethyl carbonoperoxoate (1d), 
76%, colorless oil, Rf = 0.22 (10% EA/Hex), other physical data were identical to 
literature reports.
40
 
 
 
Standard procedure for preparation of monosilylated peresters (illustrated for 8a) 
To a solution of monoacetate 1b (2.46 g, 10 mmol) in CH2Cl2 (150 mL), was added 
DMAP (0.24 g, 2.0 mmol), and Et3N (2.7 ml, 20 mmol), The reaction mixture was cooled 
to 0 
o
C and a solution of TESCl (1.5 g, 10 mmol) in CH2Cl2 (50 mL) was added dropwise 
over 10 min. The 
reaction was stirred for 30 min at 0 °C, and then the solvent was removed in vacuo. The 
residue obtained was purified by silica flash chromatography (5% EA/Hex) to give a 
colorless oily product (2.09 g, 58% yield).  
 
TESOO OOAc
 1-Acetyldioxy-1-triethylsilyldioxy-4-tert-butylcyclohexane (9a): 58%, 
colorless oil, Rf = 0.65 (20% EA/Hex); IR 2954, 1777, 1366, 1180, 865 cm
-1
; 
1
H NMR  
2.33 (d, J = 14.48Hz, 2H), 2.15 (s, 3H), 1.70 (d, J = 13.2Hz, 2H), 1.46 (dt, J = 3.78, 
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13.8Hz, 2H), 1.30 (m, 2H), 1.05 (m, 1H), 0.98 (t, J = 7.69Hz, 9H), 0.87 (s, 9H), 0.69 (dd, 
J = 7.55, 16.27Hz, 6H) ; 
13
C NMR (233K)  167.9, 110.6, 47.2, 32.5, 30.4, 27.7, 23.2, 
18.3, 7.0, 3.4; HRMS (ESI, MeOH/H2O, NaOAc), calc. for C18H36NaO5Si (M+Na)
+
: 
383.2230; found 383.2224 
 
 
TBSOO OOAc
1-Acetyldioxy-1-tert-butyldimethylsilyldioxy-4-tert-butylcyclohexane (9b): 
TESCl was replaced by TBSCl without any other change, 65%, colorless oil. Rf = 0.65 
(20% EA/Hex); IR: 2954, 2859, 1777, 1365, 1178, 873, 830, 784 cm
-1
 ; 
1
H NMR  2.33 
(m, 2H), 2.14 (s, 3H), 1.68 (m, 2H), 1.46 (dt, J = 3.85, 13.63Hz, 2H), 1.29 (m, 2H), 1.05 
(m, 1H), 0.93 (s, 9H), 0.87 (s, 9H), 0.14 (s, 6H); 
13
C NMR (233K)   167.9, 110.7, 47.2, 
32.5, 30.4, 27.7, 26.3, 23.2, 18.6, 18.3 ; HRMS (ESI, MeOH/H2O, NaOAc), calc. for 
C18H36NaO5Si (M+Na)
+
: 383.2230; found 383.2235 
 
 
 
TESOO OOAc
 1-Acetyldioxy-1-triethylsilyldioxycycloheptane (10): 81%, colorless oil. Rf 
= 0.65 (20% EA/Hex); IR: 2969, 1776, 1409, 1170, 1056, 796 cm
-1
 ; 
1
H NMR  2.08 (s, 
3H), 1.95 (m, 4H), 1.55 (br, 8H), 0.97 (t, J = 7.86 Hz, 9H), 0.68 (q, 6H); 
13
C NMR  
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115.9, 33.0, 30.2, 22.8, 17.8, 6.6, 3.7; HRMS (ESI, MeOH/H2O, NaOAc), calc. for 
C15H30NaO5Si (M+Na)
+
: 341.1760; found 341.1759 
 
 
TESOO OOA c
1-Acetyldioxy-1-triethylsilyldioxycyclooctane (11): 70%, colorless oil. Rf = 
0.65 (20% EA/Hex); IR: 2956, 1776, 1363, 1184, 1066, 833, 729 cm
-1
; 
1
H NMR  2.10 (s, 
3H), 1.97 (m, 4H), 1.56 (br, 10H), 0.97 (t, J = 7.63 Hz, 9H), 0.68 (q, 6H); 
13
C NMR 
(233K)  168.1, 115.0, 27.8, 27.2, 24.7, 22.0, 18.2, 7.0, 3.7; HRMS (ESI, MeOH/H2O, 
NaOAc), calc. for C16H32NaO5Si (M+Na)
+
: 355.1917; found 355.1906 
 
 
 
TESOO OOAc
4-Phenyl-1-acetyldioxy-1-triethylsilyldioxybutane (12): 79%, 
colorless oil. Rf = 0.65 (20% EA/Hex); IR: 2957, 1780, 1182, 1103, 825, 698 cm
-1
 ; 
1
H 
NMR  7.31 (m, 2H), 7.23 (m, 2H), 2.78 (t, J = 8.95 Hz, 2H), 2.15 (m, 5H), 1.57 (s, 3H), 
1.04 (t, J = 7.95 Hz, 9H), 0.75 (q, 6H); 
13
C NMR  141.3, 128.5, 128.3, 126.1, 111.9, 
35.5, 30.4, 18.5, 17.8, 6.7, 3.7; HRMS (ESI, MeOH/H2O, NaOAc), calc. for 
C18H30NaO5Si (M+Na)
+
: 377.1760; found 377.1756 
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TESOO OOAc
 1-Acetyldioxy-1-triethylsilyldioxynonane (13): 73%, colorless 
oil. Rf = 0.65 (20% EA/Hex); IR: 2959, 1781, 1409, 1184, 1066, 802, 729 cm
-1
 ; 
1
H NMR 
 2.04 (s, 2H), 1.69 (m, 2H), 1.30 (br, 8H), 0.93 (t, J = 7.85 Hz, 9H), 0.85 (t, J = 6.35Hz, 
6H), 0.63 (q, 6H); 
13
C NMR  114.1, 29.6, 25.5, 22.7, 17.7, 13.7, 6.5, 3.6; HRMS (ESI, 
MeOH/H2O, NaOAc), calc. for C18H30NaO5Si (M+Na)
+
: 377.1760; found 377.1768 
 
TESOO
OOAc
1-Acetyldioxy-1-triethylsilyldioxycyclododecane (14): 80%, colorless oil. 
Rf = 0.65 (20% EA/Hex); IR: 2929, 1779, 1470, 1186, 1003, 851, 728 cm
-1
; 
1
H NMR  
2.08 (s, 3H), 1.73 (m, 4H), 1.37 (br, 18H), 0.96(t, J = 7.96 Hz, 9H), 0.66 (q, 6H); 
13
C 
NMR  114.9, 26.7, 26.1, 26.0, 22.3, 21.9, 19.4, 6.7, 3.7; HRMS (ESI, MeOH/H2O, 
NaOAc), calc. for C20H40NaO5Si (M+Na)
+
: 411.2543; found 411.2536 
 
 
TESOO OOTES
1,1-Triethylsilyldioxy-4-tert-butylcyclohexane (15) 
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (0.50 g, 2.5 mmol) in 
DMF (30 mL), was added Et3N (0.76 ml, 5.4 mmol), The reaction mixture was cooled to 
-40 
o
C and TESCl (0.91 ml , 5.4 mmol) was added. The reaction was stirred for 1 hour at 
-40 °C. Upon completion of addition, the reaction was added with brine (100 mL). The 
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solution was washed extracted with hexane (50 ml) three times and then combined 
organic layer was dried over anhydrous Na2SO4. The residue obtained upon removal of 
the solvent in vacuo was purified by silica flash chromatography (5% EA/Hex) to give 
colorless oil. (0.57g, 53%), Rf = 0.80 (20% EA/Hex), other physical data were identical 
to literature reports.
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AcOO OOAc
1,1-Diacetyldioxy-4-tert-butylcyclohexane (16)  
To a solution of 4-tert-butylcyclohexyl-1,1-dihydroperoxide 1a (1.48 g, 7.2 mmol) in 
CH2Cl2 (15 mL), was added DMAP (0.09 g, 0.75 mmol), and pyridine (0.57 g, 7.2 mmol). 
The reaction mixture was cooled to 0 
o
C and a solution of Ac2O (1.48 g, 14.4 mmol) in 
CH2Cl2 (10 mL) was added dropwise over 10 min. Upon completion of addition, the 
reaction was stirred for 30 min at 0 °C, and then diluted with CH2Cl2 (100 mL). The 
solution was washed with saturated NaHCO3 (20 mL), water (20 mL), brine (20 mL), and 
then dried over anhydrous Na2SO4. The residue obtained upon removal of the solvent in 
vacuo was purified by silica flash chromatography (10% EA/Hex) to give a white solid 
(1.55 g, 75% yield). mp 54-56 °C; Rf = 0.30 (20% EA/Hex); IR: 2960, 2869, 1785, 1361, 
1187, 1057, 896 cm
-1
; 
1
H NMR  2.34 (d, J = 12.81 Hz, 2H), 2.08 (s, 3H), 2.07 (s, 3H), 
1.75 (d, J = 14.12 Hz, 2H), 1.62 (m, 2H), 1.31 (m, 2H), 1.09 (m, 1H), 0.86 (s, 9H); 
13
C 
NMR  167.5, 167.4, 111.5, 47.1, 32.2, 30.1, 27.5, 23.2, 17.5, 17.4; HRMS (ESI, 
MeOH/H2O, NaOAc), calc. for C14H24NaO6 (M+Na)
+
: 311.1471; found 311.1467 
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Standard procedure for fluoride-mediated decomposition of silylated monoesters: 
To a solution of 9a (77 mg, 0.2 mmol) and 1,3-diphenylisobenzofuran (DPBF, D, 27 mg, 
0.1 mmol) in CH3CN (2 ml), was injected TBAF (1M in THF, 0.24 ml, 0.24 mmol) 
within 5 seconds, and the reaction mixture stirred at room temperature for 5 minutes. 
Then solvent was removed by vacuum, and the residue was purified by column 
chromatography on silica gel to give the pure product D-O2 (19 mg, 66%) 
 
NMR method for quantification of oxygen transfer (illustrated for dioxygenation of 
terpenine) 
To a solution of 1b (50 mg, 0.2 mmol) and α-terpinene (T, 90%, 15 mg, 0.1 mmol) in 
CH3CN (2 ml), TBAF (1M in THF, 0.24 ml, 0.24 mmol) was injected within 5 seconds, 
and the reaction mixture stirred at room temperature for 5 minutes. Then solvent was 
removed by vacuum. Internal standard 1,2- dichloroethane was added and T-O2 was 
measured by NMR.  
The alkene peak at 6.3 ppm (dd, J = 8.56, 25.93Hz) of T-O2 will be used for calculation 
via following equations: 
Actual MoleT-O2 = Molestandard*2*AreaT-O2/Areastandard 
Therefore, the calculated %yield = 100*Actual MoleT-O2/Theoretical MoleT-O2   
Alternatively,  quantification of T-O2 can be conducted by GC/MS using a reported 
procedure
 5
 
 
GC/MS quantification of relative reactivity of dihydroperoxide monoesters 
(Illustrated for 1b and 4b)   
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Prepare a standard solution of 4-tert-butylcyclohexanone (1 mmol) and benzylacetone (1 
mmol) in CH3CN (2 ml) . The standard ratio α = Area4-tert-butylcyclohexanone 
standard/Areabenzylacetone standard. The mole ratio of the ketone products from the competitive 
reaction is  Area4-tert-butylcyclohexanone actual/( α*Areabenzylacetone actual) 
 
Standard procedure for tandem activation and decomposition of 1,1-
dihydroperoxides (Illustrated for CCl3CN activator)   
To a solution of 1a (41 mg, 0.2 mmol), CCl3CN (29 mg, 0.2 mmol) and 1,3-
diphenylisobenzofuran (DPBF, D, 27 mg, 0.1 mmol) in CH3CN (2 ml), was added 
KOtBu (90 mg, 0.8 mmol). The reaction was monitored by TLC and stirred at room 
temperature for 5 minutes. Then solvent was removed by vacuum, and the residue was 
purified by column chromatography on silica gel to give the pure product D-O2 (21 mg, 
72% yield based upon D or 36% based upon consumed 1,1-dihydroperoxide).  
 
Investigations of Reaction Order and Reaction Kinetics 
Part I. Fixed monoperester concentration unchanged, variable [TBAF].  
tBu
HOO OO Ph
O
TBAF
MeCN
tBu
O
+ 1O2
 
Conditions: 0.5mM monoperester 3mL, TBAF 15μL: Rapidly stirred THF solutions (0.5 
mM) of dihydroperoxide monoester 1c in a cuvette were individually treated with a series 
of THF solutions of TBAF ranging in concentration from 0.5 to 2.00 mM. The reaction 
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solutions were mixed and the cuvettes then placed in the UV spectrophotometer, with the 
absorbence at 272 nm monitored for 1.0 minute.  
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- = × ×
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- = × × × ×
= × × ×
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- ( ) ( )0 1Lg [TBAF] Lgn K
æ ö
= × +ç ÷
è ø
 
At the initial point, V0 is the initial rate, (Abs)0 is the initial absorbance, [Monoperester]0 
and [TBAF]0 are the initial concentration 
 
[TBAF]0/mM -d(Abs)0/dt Lg([TBAF]0) Lg(-d(Abs)0/dt) 
0.50 0.0302 -0.301 -1.520 
0.75 0.0339 -0.125 -1.470 
1.00 0.0524 0.000 -1.281 
1.25 0.0647 0.097 -1.189 
1.50 0.0789 0.176 -1.103 
1.75 0.0845 0.243 -1.073 
2.00 0.1055 0.301 -0.977 
    
Then plot Lg(-d(Abs)0/dt) vs Lg([TBAF]0) 
 
95 
 
 
n = 0.9403. This indicates the reaction is a first order reaction to TBAF reactant 
K1 = 0.05213 L ×mmol
-1 ×s-1 
 
Part II. Fixed TBAF concentration unchanged, variable [Monoperester] 
tBu
HOO OO Ph
O
TBAF
MeCN
tBu
O
+ 1O2
 
Conditions: Monoperester 3mL, TBAF 0.3M 15μL: The experiment described above was 
repeated except that the concentration of TBAF was held constant while the 
concentration of 1c was varied.  
 
y = 0.9403x - 1.2829 
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At the initial point, V0 is the initial rate, (Abs)0 is the initial absorbance, [Monoperester]0 
and [TBAF]0 are the initial concentration 
 
[Monoperester]0/mM -d(Abs)0/dt Lg([Monoperester]0) Lg(-d(Abs)0/dt) 
0.3 0.0352 -0.523 -1.453 
0.4 0.0551 -0.398 -1.259 
0.5 0.0695 -0.301 -1.158 
0.6 0.0824 -0.222 -1.084 
0.7 0.111 -0.155 -0.955 
0.8 0.113 -0.097 -0.947 
0.9 0.133 -0.046 -0.876 
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m = 1.1862. This indicates the reaction is a first order reaction to Peroxide reactant 
K2 = 0.1551 L ×mmol-1 ×s-1 
 
Part III. Calculation of apparent rate constant.  
Abs b [Monoperester]e= × ×  
[Monoperester]/mM Abs 
0.3 0.323 
0.4 0.405 
0.5 0.511 
0.6 0.612 
0.7 0.732 
0.8 0.827 
0.9 0.927 
y = 1.1862x - 0.8094 
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1.0 1.036 
 
 
be × =1.0332 L ×mmol-1 
 
With Part I result:  
K1 = 0.05213 L ×mmol
-1 ×s-1, [Monoperester]0 = 0.5 mmol ×L
-1
 
1 0
[Monoperester] bK k e= × × ×  
k = 0.101 L ×mmol-1 ×s-1 
With Part II result 
K2 = 0.1551 L ×mmol
-1 ×s-1, [TBAF]0 = 1.5 mmol ×L
-1
 
2 0[TBAF] bK k e= × × ×  
k = 0.100 L ×mmol-1 ×s-1 
Therefore the reaction constant k is 0.101 L ×mmol-1 ×s-1 
  
y = 1.0332x 
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Chapter 4 
Synthesis of a tetramic acid as a standard for identification of an intermediate in 
HSAF biosynthesis  
(Portions of the material in this chapter have been published: Lili Lou, Guoliang Qian, 
Yunxuan Xie, Jiliang Hang, Haotong Chen, Kathia Zaleta-Rivera, Yaoyao Li, Yuemao 
Shen, Patrick H. Dussault, Fengquan Liu, Liangcheng Du, Biosynthesis of HSAF, a 
Tetramic Acid-Containing Macrolactam from Lysobacter enzymogenes, J. Am. Chem. 
Soc., 2011, 133, 643-645) 
 
 
4.1 Introduction 
Heat stable antifungal factor (HSAF) is a kind of polyketide compound produced by the 
bacterium Lysobacter enzymogenes strain C3, which is used as a biological control agent 
for fungal disease of plants.
92
 The strain C3 has been demonstrated to be able to control 
many fungal diseases, including Bipolaris sorokiniana,
93
 Fusarium graminearum,
94
 
Rhizoctonia solani,
95
 and Uromyces appendiculatus.
3
 This novel polyketide compound 
HSAF, which usually affects formin-mediated microfilament assembly at hyphal tips, can 
also disrupt the formation of stable polarity axes, and thus exhibits a very high potential 
antifungal activity.
96
  
Structurally, HSAF is a type of macrolactam, containing a tetramic acid (2,4-
pyrrolidinedione) skeleton within a macrocycle fused onto a 5,5,6-tricyclic ring system. 
The tetramic acid skeleton is found widely in natural products, including Alteramide A,
97
 
100 
 
and Aburatubolactam A,
98
 and has been reported to be a key structural feature in terms of 
biological activity. (Figure 1).
99
  
 
Figure 1. Structures of tetramic acid, HSAF and related tetramic acid-containing 
macrolactams. 
 
Dr. Liangcheng Du and coworkers (UNL Department of Chemistry) reported four HSAF 
biosynthetic genes, including a hybrid polyketide synthase/nonribosomal peptide 
synthetase (PKS/NRPS).  Once they had the complete sequence of the gene cluster based 
on the genome sequences, they expressed the NRPS module and demonstrated in vitro 
that it can specifically convert two acyl thioesters and L-ornithine thioester to a tetramate 
product (Figure 2).  However, in order to confirm the structure of the biosynthetic 
product, the Du group required an authentic sample for comparison. Our collaboration 
focused on the synthesis of this tetramic acid.  
101 
 
 
Figure 2. Proposed mechanism for biosynthesis of tetramic acid-containing product  
 
4.2 Results and discussion 
The tetramic acid skeleton is generally synthesized using a Dieckmann intramolecular 
condensation as the key step.
100
 The Dieckmann condensation involves the attack of an 
ester enolate or similar nucleophile on an ester or related acyl group to generate β-
ketoesters.
101
 Several results had been reported to prepare tetramic acid derivatives via 
Dieckmann condensation (Figure 3).
102,
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Figure 3. Tetramic acid preparation via Dieckmann condensation. 
 
An alternative method for the preparation of the tetramic acid skeleton involves treatment 
of a N-protected amino acid with Meldrum’s acid in the presence of N,N-
dimethylaminopyridine and isopropenyl chloroformate to afford an intermediate, which 
rearranges to a tetramic acid upon heating (Figure 4).  .
104
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Figure 4. Alternative synthesis of tetramic acid  
 
Recently, another method for synthesis of tetramic acid derivatives has been reported 
(Figure 5). 
105
 The reaction of carbonyldiimidazole and α-diimines led to the N-alkyl-4-
alkylamino-5-methylenepyrrol-2-ones intermediates, which could be converted to 
tetramic acid derivatives in two steps. 
 
Figure 5. Synthesis of tetramic acid derivatives. 
 
A retrosynthetic summary of our planned approaches to the target molecule is illustrated 
in Figure 6. Three synthetic routes were investigated in our efforts to prepare the target 
tetramic acid. All employ Dieckmann condensation as the key step to construct the 
tetramic acid ring skeleton. 
103 
 
 
Figure 6. Retrosynthetic analysis 
 
The first route, illustrated in Scheme 1, begins with bisacylation of L-ornithine methyl 
ester (2) with stearoyl chloride to furnish diamide (3). However, the planned Dieckmann 
condensation failed to furnish the desired target tetramic acid under a variety of standard 
conditions, including the use of KOtBu, LDA, LiHMDS, or nBuLi as bases.
106
  
 
Scheme 1. Attempt of target synthesis 
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Scheme 2 illustrates an alternative route to the tetramic acid based upon Dieckmann 
condensation using the stabilized enolate derived from a 1,3-dicarbonyl as a nucleophile.  
The approach began with the N5 monocarbamate of L-ornithine methyl ester, which was 
acylated at N2 with the acid chloride of a malonic acid monoester. This intermediate 
underwent successful Dieckmann condensation with in the presence of soidum methoxide 
to furnish intermediate 6, a carboxyethyl derivative of a tetramic acid. Then 
decarboxylation of 6 in CH3NO2/H2O led to intermediate 7. Unfortunately, attempted 
introduction of the hexadecyl side chain introduction to C3 position of the 3,5-
dioxopyrrolidine failed in the typical condition of NaH/THF. This reaction instead 
furnished the enol ether derived from O-alkylation as the only product.  A similar result 
has been previously reported during attempted alkylation of tetramic acid ring systems 
with a long-chain electrophile, 
107
 suggesting that we needed to identify a route that 
would introduce the hexadecyl sidechain prior to tetramic acid formation.  
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Scheme 2. Attempt of target synthesis 
 
The successful approach to the target (Scheme 3) took advantage of the lessons gained in 
the previous route by incorporating the hexadecyl sidechain in the malonic ester deriative 
used to acylate the N2 of ornithine.  The synthesis began with the boroxazolidinone 
adduct of L-ornithine, which was selectively acylated at the terminal amino group with 
octadecanoyl chloride to furnish a monoamide.
108
 Deprotection of the boroxazolidinone 
with ethylenediamine, followed by reaction with thionyl chloride in methanol,  furnished 
methyl ester 11. Conversion of the amino acid ester to the tetramic acid was 
accomplished through a modification of a published approach.
109
 Condensation of the 
amino ester with 2-benzyloxycarbonyloctadecanoic acid 13, which was prepared in two 
steps from dibenzyl malonate, furnished the α,δ-bisamide 14 as inseparable mixture of 
diastereomers (1:1). Reaction of 14 with excess sodium hydride resulted in tandem 
Dieckmann condensation and deacylation to furnish tetramic acid 15 as a 1:1 mixture of 
epimer at C3 of the 3,5-dioxopyrrolidine. The carboxylbenzyl group is generally removed 
by catalytic hydrogenation. However, there is no evidence that sodium hydride could 
remove carboxylbenzyl group directly. A possible mechanism might be nucleophilic 
attack of the liberated sodium methoxide on the carbonyl of the benzyl ester. The 
tetrahedral intermediate can either return to an ester or else lose a dialkyl carbonate to 
generate a highly stabilized enolate.  This mechanism is probably related to the removal 
of ethoxycarbonyl group from 6 to7 in Scheme 2 
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Scheme 3. Synthesis of target molecule 
 
The synthetic tetramic acid was compared with the enzymatically synthesized material by 
LC/MS and found to have the same retention time and to generate the same mass spectra.   
 
4.3 Experimental Section 
L-ornithine monohydrochloride, 9-borabicyclononane complex (9) 
O
O
NH2
NH2B HCl
 
9 
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Compound 9 was prepared by the procedure of Fields from L-ornithine 
monohydrochloride.
4
 The product, which retained solvent, was carried on into the next 
procedure without purification. 
N5-octadecanoyl-L-ornithine, 9-borabicyclononane complex (10) 
O
O
N
H
NH2B
C17H35
O
 
10 
To a solution of compound 9 (3.06 g, 10 mmol) in THF 100 ml was added Et3N (6.0 ml, 
40 mmol) and stearoyl chloride (4.30 g, 12 mmol). The reaction mixture was stirred at rt 
for 6 h and then concentrated  in vacuo. The residue was dissolved in 200 ml water, and 
the aqueous layer was extracted with CH2Cl2 (100 ml × 3). The combined organic layers 
were dried over anhydrous Na2SO4 and filtered. The residue obtained upon concentration 
was purified by chromatography (CH2Cl2/MeOH, 95:5) to afford the octadecanoic amide 
as a  white solid 10 (4.40 g, 86%), Rf 0.6 (CH2Cl2/MeOH 90/10), Mp 69-70 ° C. [α]D = -
13.8 (CHCl3, c = 1.0).  IR 3344, 3128, 3110, 2920, 2850, 1692, 1681, 1544, 1376, 1273, 
963, 878, 722 cm
-1
; 
1
H NMR: δ6.60 (t, J= 6.4 Hz, 1H), 5.92 (t, J= 8.8 Hz, 1H), 5.01 (t, 
J= 9.6 Hz, 1H), 3.78 (t, J= 6.3 Hz, 1H), 3.28 (m, 1H), 3.20 (m, 1H), 2.16 (t, J= 7.1 Hz, 
2H), 2.05 (m, 1H), 1.94-1.12 (45H), 0.88 (t, J= 6.9 Hz, 3H), 0.57 (d, J= 10.8 Hz, 2H); 
13
C 
NMR: 175.0, 174.3, 55.1, 38.7, 36.7, 31.9, 31.7, 31.4, 31.3, 31.2, 29.73, 29.67, 29.58, 
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29.44, 29.41, 29.36, 28.1, 26.4, 25.9, 24.5, 24.0, 22.7, 14.1; HRMS (m/z) calcd for 
C31H59BN2NaO3
 
[M+Na]
+ 
: 541.4516; found: 541.4471 
 
 L-ornithine, N5-octadecanoylamide, methyl ester (11) 
 
MeO
O
N
H
NH2
C17H35
O
 
11 
Ethylene diamine (1.7 ml, 25 mmol) was added to a solution of N5-octadecanoyl-L-
ornithine, 9-borabicyclononane complex  (2.80 g, 5.5 mmol) in THF (15 ml).
4
  The 
solution was  heated to just below boiling for 1 min, and then cooled and filtered.  The 
precipitate was washed with THF (25 ml × 3), and dried in vacuo to give a white solid, 
which was suspended in MeOH (100 ml). SOCl2  (1.9 ml, 25 mmol) was added dropwise, 
and the reaction mixture was refluxed for 2 h. After removal of solvent in vacuo,  the 
residue was dissolved in water 100 ml. The solution was adjusted to pH 10 with  sat. aq. 
K2CO3, and then extracted with CH2Cl2 (50 ml × 3). The combined organic layers were 
dried over anhydrous Na2SO4, and the filtrate concentrated in vacuo to afford 11 as a 
white solid (2.26 g, 92%), which was used without further purification. Rf 0.3 
(CH2Cl2/MeOH/NEt3 90/10/1),   Mp 59-61 ° C; [α]D = -7.1 (CHCl3, c = 1.0). IR 3318, 
2916, 2848, 1741, 1646, 1553, 1232, 718 cm
-1
; 
1
H NMR: 6.01 (t, J= 5.4 Hz, 1H), 3.70 (s, 
3H), 3.44 (t, J= 6.9 Hz, 1H), 3.24 (m, 2H), 2.13 (t, J = 7.2 Hz, 2H), 1.60 (m, 4H), 1.30-
1.21 (32H), 0.86 (t, J = 6.9 Hz, 3H); 
13
C NMR: 176.2, 173.2, 54.0, 52.1, 39.0, 26.8, 32.1, 
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31.9, 29.67, 29.63, 29.5, 29.37, 29.33, 25.9, 25.8, 22.7, 14.1; HRMS (m/z) calcd for 
C24H48N2NaO3
 
[M+Na]
+ 
: 435.3563; found: 435.3562. Small impurities could be seen in 
1
H NMR at 3.65 ppm and 2.28 ppm 
 
2-(Benzyloxycarbonyl)octadecanoic acid, benzyl ester (12) 
BnO
O O
OBn
C16H33  
12 
Dibenzylmalonate (2.84 g, 10 mmol) was added to a stirred solution of NaH (0.24 g, 10 
mmol) in dry THF (10 ml) and dry DMF (10 ml) and the mixture was stirred at rt for 1 h. 
1-Iodohexadecane (3.52 g, 10 mmol) was then added and the reaction mixture was 
refluxed for 3 h. The cooled reaction mixture was concentrated in vacuo and the residue 
added to sat. aq. NH4Cl (100 ml), and the aqueous layer was extracted by Et2O (100 ml × 
3). The combined organic layers were dried over anhydrous Na2SO4 and the filtrate was 
concentrated in vacuo. Flash chromatography (Hexane/EtOAc, 95:5) afforded the diester 
as a low-melting white solid 12 (4.67 g, 92%). Rf 0.3 (Hexane/EtOAc 95/5). Mp 41-42 ° 
C; IR 2914, 2848, 1752, 1728, 1463, 1455, 1184,1143, 724, 669 cm
-1
; 
1
H NMR: δ7.34 
(m, 10H), 5.19 (s, 4H), 3.48 (t, J= 7.5 Hz, 1H), 1.97 (dd, J= 7.1 Hz, 13.8 Hz, 2H), 1.38-
1.21 (28H), 0.93 (t, J= 7.0 Hz, 3H); 
13
C NMR:δ169.3, 135.5, 128.6, 128.3, 128.2, 67.0, 
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52.1, 32.0, 29.73, 29.69, 29.64, 29.5, 29.4, 29.3, 29.2, 28.8, 27.2, 22.7, 14.2 ; HRMS (m/z) 
calcd for C33H48NaO4
 
[M+Na]
+
: 531.3450; found: 531.3411 
 
2-(Benzyloxycarbonyl)octadecanoic acid (13)  was prepared by a modification of a 
procedure reported for malonic acid monobenzyl ester  
BnO
O O
OH
C16H33  
13 
To a suspension of KOH (0.28 g, 5 mmol) in benzyl alcohol (5.0 ml) was added 
gradually to a solution of the diester (2.62 g, 5 mmol) in benzyl alcohol (25 ml). The 
reaction mixture was stirred at rt for 24 h, and the solvent was then removed in vacuo. 
The residue was dissolved in water (100 ml) and the solution acidified to pH 2 with 3 M 
HCl. The aqueous layer was extracted with CH2Cl2 (100 ml × 3) and then combined 
organic layers were dried over anhydrous Na2SO4.  The filtrate was concentrated in vacuo 
to afford a solid which was recrystallized from heptane to afford the monoester as a white 
solid 13 (1.69 g, 81%): Rf 0.6 (Hexane/EtOAc/AcOH 20/20/1). Mp 46-48 °C; IR 2916, 
2848, 1745, 1696, 1470, 1259, 1231, 936, 730, 718 cm
-1
; 
1
H NMR: δ10.08 (br, 1H), 
7.40 (m, 5H), 5.23 (s, 2H), 3.47 (t, J= 7.4 Hz, 1H), 1.97 (m, 2H), 1.40-1.24 (28H), 0.92 (t, 
J= 6.7 Hz, 3H); 
13
C NMR: 175.2, 169.3, 135,3, 128.6, 128.4, 128.2, 67.3, 51.7, 32.0, 
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29.73, 29.69, 29.63, 29.5, 29.39, 29.31, 29.2, 28.9, 27.2, 22.7, 14.1; HRMS (m/z) calcd 
for C26H42NaO4
  
[M+Na]
+
: 441.2981; found: 441.2993. 
L-ornithine,N5-octadecanoylamide-N2-(2-benzyloxycarbonyl)octadecanoylamide (14) 
MeO
O
N
H
HN
C17H35
O
O
C16H33
COOBn
 
14 
To a solution of compound 11 (0.20 g, 0.48 mmol) in CH2Cl2 (20 ml) was sequentially 
added N,N'-dicyclohexylcarbodiimide (0.12 g, 0.58 mmol) and monoester 13 (0.20 g, 
0.48 mmol). The reaction mixture was refluxed for 4 h, cooled to rt, and then filtered. 
The filtrate was dried over anhydrous Na2SO4, and then refiltered before being 
concentrated in vacuo. Flash chromatography (Hexane/EtOAc, 60:40) afforded 14 as a 
white solid (0.28 g, 72%), Rf 0.4 (Hexane/EtOAc 50/50). Mp 100-101 °C; IR 3304, 2916, 
2849, 1736, 1639, 1545, 1272, 1236, 720, 695 cm
-1
; 
1
H NMR: δ7.37 (m, 5H), 7.17 (d, 
J= 7.5 Hz, 0.5H), 7.13 (d, J= 7.8 Hz, 0.5H, isomer), 5.72 (t, J= 6.3 Hz, 1H), 5.20 (m, 2H), 
4.58 (m, 1H), 3.75 (s, 1.5H), 3.74(s, 1.5H, isomer), 3.31 (dd, J= 7.1, 14.3 Hz, 1H), 3.24 
(m, 2H), 2.15 (m, 2H), 1.86 (m, 4H), 1.65-1.25 (60H), 0.89 (t, J= 6.9 Hz, 6H); 
13
C NMR 
173.38, 173.31(isomer), 172.3, 172.2(isomer), 171.7, 171.4(isomer), 168.4, 
168.3(isomer), 135.32, 135.29(isomer), 128.6, 128.5, 128.4, 67.2, 52.95, 52.86(isomer), 
52.51, 52.48(isomer), 51.93, 51.91(isomer), 38.6, 26.8, 31.9, 30.9, 30.5, 29.71, 29.66, 
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29.5, 29.40, 29.37, 29.22, 29.17, 27.25, 27.21, 25.8, 25.4, 22.7, 14.1 ; HRMS (m/z
 
calcd 
for C50H88N2NaO6
 
) [M+Na]
+
: 835.6540; found: 835.6465. 
3-Hexadecyl-5-(3-aminopropyl)-pyrrolidine-2,4-one, octadecanoyl amide (1) was 
prepared using a modification of a procedure reported for other tetramic acids.
 
NH
O
O
C16H33
N
H
O
C17H35
 
1 
NaH (60% dispersion in mineral oil, 13 mg, 0.37 mmol) was washed with pentane 20 ml 
three times in a 100ml RB flask, then compound 14 (81 mg, 0.10 mmol) was added in 
THF (10 ml). The reaction mixture was refluxed for 6 h and then cooled to rt. After 
removal of solvent in vacuo, the residue was suspended in water (15 ml) and the solution 
acidified to pH 2 with 3 M HCl. The combined CH2Cl2 extracts (10 ml × 3) were dried 
over anhydrous Na2SO4 and the filtrate concentrated in vacuo. Flash chromatography 
(CH2Cl2/MeOH, 95:5) afforded 1 as a white solid (48 mg, 74%). Rf 0.5 (CH2Cl2/MeOH 
90/10). Mp 108-109 °C. IR 2916, 2848, 1686, 1639, 1467, 720 cm
-1
; 
1
H NMR: δ6.94 (d, 
J= 3.9 Hz, 0.5H), 6.88 (d, J= 8.4 Hz, 0.5H, isomer), 5.60 (t, J= 5.4 Hz, 1H), 4.01 (t, J= 
6.7 Hz, 0.5H), 3.92 (t, J= 5.4 Hz, 0.5H, isomer), 3.29 (m, 2H), 2.83 (t, J= 5.8 Hz, 0.5H), 
2.76 (t, J= 5.8 Hz, 0.5H, isomer), 2.17 (t, J= 7.6 Hz, 2H),1.91-1.56(8H), 1.47-1.20 (56H), 
0.90 (t, J= 6.6 Hz, 3H); 
13
C NMR (150 MHz): 211.1, 210.7 (isomer), 174.2, 173.9 
(isomer), 173.6, 62.3, 61.9(isomer), 49.7, 49.1(isomer), 38.5, 36.8, 31.9, 29.71, 29.67, 
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29.58, 29.52, 29.37, 29.34, 29.31, 28.7, 27.2, 26.6, 26.5, 26.20, 25.9, 25.8, 25.5, 22.7, 
14.1; HRMS (m/z) calcd for C41H78N2NaO3
+
 [M+Na]
+
: 669.5910; found: 669.5889 
 
LC/MS analysis 
Tetramic acid 1 was subjected to LC/MS under the following conditions:  
LC/MS column Alltima C18LL (5u, 1.0mm * 250 mm); solvent A H2O containing 5 mM 
ammonium acetate; solvent B MeOH containing 5 mM ammonium acetate. Flow rate 
was 50 µl/min, with a gradient system (0-5 min, 30% B; 5-20 min, 30% B to 100% B 
gradient; 20-30 min, 100% B; 30-40 min, 100% B to 30% B gradient; 40-45 min, 30% B). 
One of the main signals observed, at 25.8 minutes,  coincided exactly with the signal 
observed for material derived from the biosynthetic pathway described in the introduction. 
For both the synthetic material and the material derived from the biosynthetic pathway, 
the peak at 25.8 minutes gave a mass spectrum the major peak at 647.6080.   
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